Publications
Search Google Scholar | Search PubMed
2014
Khabiry, Masoud; Jalili, Nader; Sridhar, Srinivas
Automated cell counting method for microgroove based microfluidic device Proceedings Article
In: 2014 40th Annual Northeast Bioengineering Conference (NEBEC), pp. 1–2, IEEE 2014.
Abstract | BibTeX | Tags: Nanomedicine
@inproceedings{khabiry2014automated,
title = {Automated cell counting method for microgroove based microfluidic device},
author = {Masoud Khabiry and Nader Jalili and Srinivas Sridhar},
year = {2014},
date = {2014-01-01},
booktitle = {2014 40th Annual Northeast Bioengineering Conference (NEBEC)},
pages = {1--2},
organization = {IEEE},
abstract = {Microfluidic grooves and channels enable the control of cell positioning and capturing of cells in cell-based biosensor applications. Microfluidic devices also provide a platform for cell-based biological assays. Microfluidic channels have been used to capture cells for various cell-based diagnostics and screening applications. The number of cells and cell locations are important factors which will affect the flow pattern in the microfluidic device and consequently induced shear stresses. Moreover, manual cell counting and cell information extraction is a time consuming and tedious task. Automated techniques reduce human errors and expedite the process. Furthermore, it facilitates extraction of information from obtained images for further fluidic analysis.},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {inproceedings}
}
van de Ven, Anne L; Geilich, Benjamin; Gharagouzloo, Codi; Barlow, Jacob; Webster, Thomas; Sridhar, Srinivas
Polymersomes for image-guided therapy Proceedings Article
In: 2014 40th Annual Northeast Bioengineering Conference (NEBEC), pp. 1–2, IEEE 2014.
Abstract | BibTeX | Tags: Nanomedicine
@inproceedings{van2014polymersomes,
title = {Polymersomes for image-guided therapy},
author = {Anne L van de Ven and Benjamin Geilich and Codi Gharagouzloo and Jacob Barlow and Thomas Webster and Srinivas Sridhar},
year = {2014},
date = {2014-01-01},
booktitle = {2014 40th Annual Northeast Bioengineering Conference (NEBEC)},
pages = {1--2},
organization = {IEEE},
abstract = {Polymersomes are a promising avenue for image-guided therapy of cancer, since they can stably encapsulate a broad range of therapeutic molecules and offer both targeting capacity and stimuli responsiveness. We have formulated highly stable, magnetically activatable polymersomes capable of continuous and pulsed small molecule release. In the proof-of-concept provided here, we demonstrate that these particles are responsive to both external and heat and magnetic fields. At physiologic temperatures, these particles display a sustained release profile that can be reversibly triggered for transient increases in release. The incorporation of fluorescent and iron oxide contrast sources make these particles amenable for quantitative imaging techniques including intravital microscopy (IVM) and ultra-short time-to-echo (UTE) magnetic resonance imaging (MRI). Thus we believe this formulation is uniquely suited for the in vivo study and optimization of externally triggered tumor growth inhibition.},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {inproceedings}
}
Ngwa, W; Altundal, Y; Korideck, H; Kumar, R; Sridhar, S; Cormack, R; Makrigiorgos, M
Radiation Therapy Biomaterials for Response Assessment and Nodal Detection (Brand) Journal Article
In: International Journal of Radiation Oncology• Biology• Physics, vol. 90, no. 1, pp. S856, 2014.
Abstract | BibTeX | Tags: Nanomedicine
@article{ngwa2014radiation,
title = {Radiation Therapy Biomaterials for Response Assessment and Nodal Detection (Brand)},
author = {W Ngwa and Y Altundal and H Korideck and R Kumar and S Sridhar and R Cormack and M Makrigiorgos},
year = {2014},
date = {2014-01-01},
journal = {International Journal of Radiation Oncology• Biology• Physics},
volume = {90},
number = {1},
pages = {S856},
publisher = {Elsevier},
abstract = {Purpose/Objective(s)
We propose that routinely used inert radiation therapy (RT) biomaterials (e.g. fiducials, spacers) can be upgraded to smart ones by incorporating multifunctional non-toxic gold nanoparticles (GNPs) for sustained in-situ release. Our hypothesis is that the GNPs released, after implantation of the smart biomaterial in tumor, can be programmed to label/brand metastatic or circulating tumor cells (CTCs) at their source before they are shed into hematogenous or lymphatic circulation. This would enable significantly enhanced CTCs detection by different methods. In this work, we developed and characterized such prototype smart biomaterials. We also assessed the potential for released GNPs to label/brand CTCs over time for enhanced detection by photoacoustic methods.
Materials/Methods
Prototype smart biomaterials were produced by coating inert fiducials with a polymer film loaded with GNPs. In vitro release of GNPs was monitored by UV-Vis Spectroscopy over time. An experimentally determined diffusion coefficient (D) for 10 nm nanoparticles in mouse prostate tumor model was employed to estimate D for other nanoparticle sizes using the Stoke-Einstein equation. The error function diffusion model in the experimental study was applied to calculate the diffusion time required to label any CTCs within the tumor volume. CTCs were considered labeled when in contact with an experimentally determined minimum GNPs concentration (37ng/g) detectable by photoacoustic methods. The study was done for a range of tumor sizes and initial concentrations.
Results
Our prototype smart biomaterial showed sustained customizable release of GNP in vitro, with release profile reaching steady state after 2 hours. Meanwhile, for the experimentally determined D, results using an initial concentration of 7 mg/g showed it would take 7.6-17.3 days for the released GNP to brand any CTCs located within the tumor volume of diameter 2-3 cm. The labeling time decreased with decrease in GNP size or increase in initial concentration.
Conclusions
Considered together, our results demonstrate potential for labeling CTCs right from the source tumor, with the labeling customizable through nanoparticle design: size, initial concentration, etc. The highest clinical impact of this innovative approach is anticipated in significantly enhancing the isolation and detection efficiency of CTCs in circulation or lymph nodes towards improved characterization of tumor aggressiveness, treatment response, or prognosis. The ability to brand and track CTCs right from their source could also lead to a better understanding of mechanisms contributing to cancer progression or metastasis. The innovative approach would come at no additional inconvenience to RT patients who are candidates for the currently used inert RT biomaterials.},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
We propose that routinely used inert radiation therapy (RT) biomaterials (e.g. fiducials, spacers) can be upgraded to smart ones by incorporating multifunctional non-toxic gold nanoparticles (GNPs) for sustained in-situ release. Our hypothesis is that the GNPs released, after implantation of the smart biomaterial in tumor, can be programmed to label/brand metastatic or circulating tumor cells (CTCs) at their source before they are shed into hematogenous or lymphatic circulation. This would enable significantly enhanced CTCs detection by different methods. In this work, we developed and characterized such prototype smart biomaterials. We also assessed the potential for released GNPs to label/brand CTCs over time for enhanced detection by photoacoustic methods.
Materials/Methods
Prototype smart biomaterials were produced by coating inert fiducials with a polymer film loaded with GNPs. In vitro release of GNPs was monitored by UV-Vis Spectroscopy over time. An experimentally determined diffusion coefficient (D) for 10 nm nanoparticles in mouse prostate tumor model was employed to estimate D for other nanoparticle sizes using the Stoke-Einstein equation. The error function diffusion model in the experimental study was applied to calculate the diffusion time required to label any CTCs within the tumor volume. CTCs were considered labeled when in contact with an experimentally determined minimum GNPs concentration (37ng/g) detectable by photoacoustic methods. The study was done for a range of tumor sizes and initial concentrations.
Results
Our prototype smart biomaterial showed sustained customizable release of GNP in vitro, with release profile reaching steady state after 2 hours. Meanwhile, for the experimentally determined D, results using an initial concentration of 7 mg/g showed it would take 7.6-17.3 days for the released GNP to brand any CTCs located within the tumor volume of diameter 2-3 cm. The labeling time decreased with decrease in GNP size or increase in initial concentration.
Conclusions
Considered together, our results demonstrate potential for labeling CTCs right from the source tumor, with the labeling customizable through nanoparticle design: size, initial concentration, etc. The highest clinical impact of this innovative approach is anticipated in significantly enhancing the isolation and detection efficiency of CTCs in circulation or lymph nodes towards improved characterization of tumor aggressiveness, treatment response, or prognosis. The ability to brand and track CTCs right from their source could also lead to a better understanding of mechanisms contributing to cancer progression or metastasis. The innovative approach would come at no additional inconvenience to RT patients who are candidates for the currently used inert RT biomaterials.
Cormack, R; Ngwa, W; Tangutoori, S; Rajiv, K; Sridhar, S; Makrigiorgos, G
SU-F-19A-08: Optimal Time Release Schedule of In-Situ Drug Release During Permanent Prostate Brachytherapy Journal Article
In: Medical Physics, vol. 41, no. 6Part22, pp. 389–390, 2014.
BibTeX | Tags: Nanomedicine
@article{cormack2014f,
title = {SU-F-19A-08: Optimal Time Release Schedule of In-Situ Drug Release During Permanent Prostate Brachytherapy},
author = {R Cormack and W Ngwa and S Tangutoori and K Rajiv and S Sridhar and G Makrigiorgos},
year = {2014},
date = {2014-01-01},
journal = {Medical Physics},
volume = {41},
number = {6Part22},
pages = {389--390},
publisher = {American Association of Physicists in Medicine},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
2013
Petrov, Yury; Sridhar, Srinivas
Electric Field Encephalography: Electric fields and their application to functional brain imaging. Journal Article
In: 2013.
Abstract | BibTeX | Tags: Neurotechnology
@article{petrovelectric,
title = {Electric Field Encephalography: Electric fields and their application to functional brain imaging.},
author = {Yury Petrov and Srinivas Sridhar},
year = {2013},
date = {2013-07-03},
abstract = {We introduce the notion of Electric Field Encephalography (EFEG) based on measuring electric fields of the brain and demonstrate, using computer modeling, that given the appropriate electric field sensors this technique may have significant advantages over the current EEG technique. Unlike EEG, EFEG can be used to measure brain activity in a contactless and reference-free manner at significant distances from the head surface. Principal component analysis using simulated cortical sources demonstrated that electric field sensors positioned 3 cm away from the scalp and characterized by the same signal-to-noise ratio as EEG sensors provided the same number of uncorrelated signals as scalp EEG. When positioned on the scalp, EFEG sensors provided 2–3 times more uncorrelated signals. This significant increase in the number of uncorrelated signals can be used for more accurate assessment of brain states for non-invasive brain-computer interfaces and neurofeedback applications. It also may lead to major improvements in source localization precision
},
keywords = {Neurotechnology},
pubstate = {published},
tppubtype = {article}
}
Yavuzcetin, O; Perry, Nicholas R; Malley, Sean T; Dally, Rebecca L; Novikov, Herman P; Ozturk, Birol; Sridhar, Srinivas
Fabrication and characterization of single mode annealed proton exchanged waveguides in-x-cut lithium niobate Journal Article
In: Optical Materials, vol. 36, no. 2, pp. 372–375, 2013.
Abstract | BibTeX | Tags: Sensors
@article{yavuzcetin2013fabrication,
title = {Fabrication and characterization of single mode annealed proton exchanged waveguides in-x-cut lithium niobate},
author = {O Yavuzcetin and Nicholas R Perry and Sean T Malley and Rebecca L Dally and Herman P Novikov and Birol Ozturk and Srinivas Sridhar},
year = {2013},
date = {2013-01-01},
journal = {Optical Materials},
volume = {36},
number = {2},
pages = {372--375},
publisher = {North-Holland},
abstract = {Lithium niobate is a key, well-known material in optical communication that maintains its importance due to its high speed in electro-optical modulators and other optical devices. Using a benzoic acid proton exchange method and annealing in wet O2, we have fabricated waveguides along the y-axis of -x-cut lithium niobate substrate. We have optimized proton exchange and annealing time to make waveguides with the highest transmission we observed to date. The optical transmission was measured in waveguides between 3 μm and 7 μm in width, and 10 mm in length. The near-field mode properties of the waveguides were also examined. In addition, we discovered that the transmission through waveguides is reduced by the surface residues which are underestimated in most fabrication processes. This paper outlines the full fabrication process as well as characterization methods in detail, including a supercontinuum laser source.},
keywords = {Sensors},
pubstate = {published},
tppubtype = {article}
}
Gharagouzloo, CA; Madi, S; Seethamraju, RT; Harisinghani, M; Sridhar, S
Ultrashort TE imaging with SPIONs: bright prospects for in vivo applications Proceedings Article
In: JOURNAL OF NUCLEAR MEDICINE, pp. 9–9, SOC NUCLEAR MEDICINE INC 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA 2013.
@inproceedings{gharagouzloo2013ultrashort,
title = {Ultrashort TE imaging with SPIONs: bright prospects for in vivo applications},
author = {CA Gharagouzloo and S Madi and RT Seethamraju and M Harisinghani and S Sridhar},
year = {2013},
date = {2013-01-01},
booktitle = {JOURNAL OF NUCLEAR MEDICINE},
volume = {54},
pages = {9--9},
organization = {SOC NUCLEAR MEDICINE INC 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA},
keywords = {MRI},
pubstate = {published},
tppubtype = {inproceedings}
}
Gharagouzloo, Codi; Jillela, Manasa; Kumar, Rajiv; Nagesha, Dattatri; Sridhar, Srinivas
Positive contrast imaging of magnetic nanoplatforms for image-guided drug delivery. Miscellaneous
2013.
@misc{gharagouzloo2013positive,
title = {Positive contrast imaging of magnetic nanoplatforms for image-guided drug delivery.},
author = {Codi Gharagouzloo and Manasa Jillela and Rajiv Kumar and Dattatri Nagesha and Srinivas Sridhar},
year = {2013},
date = {2013-01-01},
publisher = {American Association for Cancer Research},
abstract = {During the last 2 decades no new clinical MRI agents have been approved for clinical use. While Gadolinium based agents have been very popular, Gd cannot be used in emerging multi-functional nano platforms that have the potential to be retained in the body leading to severe toxicity. Superparamagnetic iron-oxide nanoparticles (SPIONs) are most attractive as offering a significant alternative that is far less toxic than Gd based agents. They can be incorporated into nanoplatforms combining other therapeutic agents to achieve image guided drug delivery. Conventionally, SPIONs are imaged via T2 and T2* weighted techniques which manifest signal voids for SPION-containing media. This proves to be disadvantageous in most circumstances because of the difficulty in discriminating signal loss from tissue associated partial voluming, perivascular effects, susceptibility artifacts and motion or flow artifacts. The unique combination of SPIONs with ultra-short TE (UTE) imaging has the specific advantages of rendering positive contrast with high SNR and high CNR, since non-SPION containing regions are dramatically dark due to native tissue's comparatively higher T1. With UTE, it may be possible to take advantage of SPION's inherent biocompatibility allowing for incorporation into drug loaded nanoplatforms leading to bright contrast and the possibility of in vivo quantification.
Here, we report on a systematic study of positive contrast MR imaging using magnetic nanoplatforms incorporating SPIONs of varying particle size and functionalization. In the first step, nanoparticles of various sizes from 4 nm to 20 nm were synthesized by the thermal decomposition method in organic solvents and then coated with phospholipids containing PEG. The use of PEGylated phospholipid enables water solubility, imparts better dispersity and long circulation in blood stream. This results in a core-shell like morphology with iron oxide nanoparticle forming the core and phospholipid PEG forming the shell. The nanoparticles were characterized for their size and morphology using dynamic light scattering (DLS) and transmission electron microscopy (TEM). UTE was optimized on a Bruker 7T Biospec at the Center for Translational Neuroimaging (CTNI) at Northeastern University. High-contrast images were obtained by modification of various imaging parameters such as TE, TR, flip angle, pulse length, polar under-sampling, bandwidth and FOV/Geometry. The results are compared in vivo with Feraheme and show good promise for this approach to MR nanoparticle imaging.
We acknowledge partial support from NSF DGE 0965843, HHS/5U54CA151881-02, and the Electronics Materials Research Institute at Northeastern University.
Citation Format: Codi Gharagouzloo, Manasa Jillela, Rajiv Kumar, Dattatri Nagesha, Srinivas Sridhar. Positive contrast imaging of magnetic nanoplatforms for image-guided drug delivery. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2673. doi:10.1158/1538-7445.AM2013-2673
©2013 American Association for Cancer Research},
keywords = {MRI},
pubstate = {published},
tppubtype = {misc}
}
Here, we report on a systematic study of positive contrast MR imaging using magnetic nanoplatforms incorporating SPIONs of varying particle size and functionalization. In the first step, nanoparticles of various sizes from 4 nm to 20 nm were synthesized by the thermal decomposition method in organic solvents and then coated with phospholipids containing PEG. The use of PEGylated phospholipid enables water solubility, imparts better dispersity and long circulation in blood stream. This results in a core-shell like morphology with iron oxide nanoparticle forming the core and phospholipid PEG forming the shell. The nanoparticles were characterized for their size and morphology using dynamic light scattering (DLS) and transmission electron microscopy (TEM). UTE was optimized on a Bruker 7T Biospec at the Center for Translational Neuroimaging (CTNI) at Northeastern University. High-contrast images were obtained by modification of various imaging parameters such as TE, TR, flip angle, pulse length, polar under-sampling, bandwidth and FOV/Geometry. The results are compared in vivo with Feraheme and show good promise for this approach to MR nanoparticle imaging.
We acknowledge partial support from NSF DGE 0965843, HHS/5U54CA151881-02, and the Electronics Materials Research Institute at Northeastern University.
Citation Format: Codi Gharagouzloo, Manasa Jillela, Rajiv Kumar, Dattatri Nagesha, Srinivas Sridhar. Positive contrast imaging of magnetic nanoplatforms for image-guided drug delivery. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2673. doi:10.1158/1538-7445.AM2013-2673
©2013 American Association for Cancer Research
Ngwa, Wilfred; Korideck, Houari; Kassis, Amin I; Kumar, Rajiv; Sridhar, Srinivas; Makrigiorgos, Mike G; Cormack, Robert A
In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds Journal Article
In: Nanomedicine: Nanotechnology, Biology and Medicine, vol. 9, no. 1, pp. 25–27, 2013.
Abstract | BibTeX | Tags: Nanomedicine
@article{ngwa2013vitro,
title = {In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds},
author = {Wilfred Ngwa and Houari Korideck and Amin I Kassis and Rajiv Kumar and Srinivas Sridhar and Mike G Makrigiorgos and Robert A Cormack},
year = {2013},
date = {2013-01-01},
journal = {Nanomedicine: Nanotechnology, Biology and Medicine},
volume = {9},
number = {1},
pages = {25--27},
publisher = {Elsevier},
abstract = {This communication reports the first experimental evidence of gold nanoparticle (AuNP) radiosensitization during continuous low-dose-rate (LDR) gamma irradiation with low-energy brachytherapy sources.
This communication reports the first experimental evidence of gold nanoparticle (AuNP) radiosensitization during continuous low-dose-rate (LDR) gamma irradiation with low-energy brachytherapy sources. HeLa cell cultures incubated with and without AuNP were irradiated with an I-125 seed plaque designed to produce a relatively homogeneous dose distribution in the plane of the cell culture slide. Four sets of irradiation experiments were conducted at low-dose rates ranging from 2.1 to 4.5 cGy/h. Residual γH2AX was measured 24 h after irradiation and used to compare radiation damage to the cells with and without AuNP. The data demonstrate that the biological effect when irradiating in the presence of 0.2 mg/ml concentration of AuNP is about 70%–130% greater than without AuNP. Meanwhile, without radiation, the AuNP showed minimal effect on the cancer cells. These findings provide in vitro evidence that AuNP may be employed as radiosensitizers during continuous LDR brachytherapy.
},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
This communication reports the first experimental evidence of gold nanoparticle (AuNP) radiosensitization during continuous low-dose-rate (LDR) gamma irradiation with low-energy brachytherapy sources. HeLa cell cultures incubated with and without AuNP were irradiated with an I-125 seed plaque designed to produce a relatively homogeneous dose distribution in the plane of the cell culture slide. Four sets of irradiation experiments were conducted at low-dose rates ranging from 2.1 to 4.5 cGy/h. Residual γH2AX was measured 24 h after irradiation and used to compare radiation damage to the cells with and without AuNP. The data demonstrate that the biological effect when irradiating in the presence of 0.2 mg/ml concentration of AuNP is about 70%–130% greater than without AuNP. Meanwhile, without radiation, the AuNP showed minimal effect on the cancer cells. These findings provide in vitro evidence that AuNP may be employed as radiosensitizers during continuous LDR brachytherapy.
Rivera-Chacon, DM; Alvarado-Velez, M; Acevedo-Morantes, CY; Singh, SP; Gultepe, E; Nagesha, D; Sridhar, S; Ramirez-Vick, JE
Fibronectin and vitronectin promote human fetal osteoblast cell attachment and proliferation on nanoporous titanium surfaces Journal Article
In: Journal of biomedical nanotechnology, vol. 9, no. 6, pp. 1092–1097, 2013.
Abstract | BibTeX | Tags: Nanomedicine
@article{rivera2013fibronectin,
title = {Fibronectin and vitronectin promote human fetal osteoblast cell attachment and proliferation on nanoporous titanium surfaces},
author = {DM Rivera-Chacon and M Alvarado-Velez and CY Acevedo-Morantes and SP Singh and E Gultepe and D Nagesha and S Sridhar and JE Ramirez-Vick},
year = {2013},
date = {2013-01-01},
journal = {Journal of biomedical nanotechnology},
volume = {9},
number = {6},
pages = {1092--1097},
publisher = {American Scientific Publishers},
abstract = {We studied the influence of the serum proteins fibronectin (FN) and vitronectin (VN) with nanoporous TiO2 on osteoblast cell attachment. Taken together, these results suggest that the nanoporous surface topography results in increased adsorbtion of FN and VN the slow release of these proteins are important factors in osteoblast attachment to titanium alloys.
Improvements in osteoconduction of implant biomaterials require focusing on the bone-implant interface, which is a complex multifactorial system. Surface topography of implants plays a crucial role at this interface. Nanostructured surfaces have been shown to promote serum protein adsorption and osteoblast adhesion when compared to micro-structured surfaces for bone-implant materials. We studied the influence of the serum proteins fibronectin and vitronectin on the attachment and proliferation of osteoblasts onto nanostructured titania surfaces. Human fetal osteoblastic cells hFOB 1.19 were used as model osteoblasts and were grown on nanoporous TiO2 templates, using Ti6Al4V and commercially pure Ti substrates as controls. Results show a significant increase in cell proliferation on nanoporous TiO2 over flat substrates. Initial cell attachment data exhibited a significant effect by either fibronectin or vitronectin on cell adhesion at the surface of any of the tested materials. In addition, the extent of cell adhesion was significantly different between the nanoporous TiO2 and both Ti6Al4V and commercially pure Ti substrates, with the first showing the highest surface coverage. There was no significant difference on osteoblast attachment or proliferation between the presence of fibronectin or vitronectin using any of the material substrates. Taken together, these results suggest that the increase in osteoblast attachment and proliferation shown on the nanoporous TiO2 is due to an increase in the adsorption of fibronectin and vitronectin because of the higher surface area and to an enhanced protein unfolding, which allows access to osteoblast binding motifs within these proteins.},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Improvements in osteoconduction of implant biomaterials require focusing on the bone-implant interface, which is a complex multifactorial system. Surface topography of implants plays a crucial role at this interface. Nanostructured surfaces have been shown to promote serum protein adsorption and osteoblast adhesion when compared to micro-structured surfaces for bone-implant materials. We studied the influence of the serum proteins fibronectin and vitronectin on the attachment and proliferation of osteoblasts onto nanostructured titania surfaces. Human fetal osteoblastic cells hFOB 1.19 were used as model osteoblasts and were grown on nanoporous TiO2 templates, using Ti6Al4V and commercially pure Ti substrates as controls. Results show a significant increase in cell proliferation on nanoporous TiO2 over flat substrates. Initial cell attachment data exhibited a significant effect by either fibronectin or vitronectin on cell adhesion at the surface of any of the tested materials. In addition, the extent of cell adhesion was significantly different between the nanoporous TiO2 and both Ti6Al4V and commercially pure Ti substrates, with the first showing the highest surface coverage. There was no significant difference on osteoblast attachment or proliferation between the presence of fibronectin or vitronectin using any of the material substrates. Taken together, these results suggest that the increase in osteoblast attachment and proliferation shown on the nanoporous TiO2 is due to an increase in the adsorption of fibronectin and vitronectin because of the higher surface area and to an enhanced protein unfolding, which allows access to osteoblast binding motifs within these proteins.
Faegh, Samira; Jalili, Nader; Sridhar, Srinivas
A self-sensing piezoelectric microcantilever biosensor for detection of ultrasmall adsorbed masses: theory and experiments Journal Article
In: Sensors, vol. 13, no. 5, pp. 6089–6108, 2013.
Abstract | BibTeX | Tags: Sensors
@article{faegh2013self,
title = {A self-sensing piezoelectric microcantilever biosensor for detection of ultrasmall adsorbed masses: theory and experiments},
author = {Samira Faegh and Nader Jalili and Srinivas Sridhar},
year = {2013},
date = {2013-01-01},
urldate = {2013-01-01},
journal = {Sensors},
volume = {13},
number = {5},
pages = {6089--6108},
publisher = {Multidisciplinary Digital Publishing Institute},
abstract = {Detection of ultrasmall masses such as proteins and pathogens has been made possible as a result of advancements in nanotechnology. Development of label-free and highly sensitive biosensors has enabled the transduction of molecular recognition into detectable physical quantities. Microcantilever (MC)-based systems have played a widespread role in developing such biosensors. One of the most important drawbacks of all of the available biosensors is that they all come at a very high cost. Moreover, there are certain limitations in the measurement equipments attached to the biosensors which are mostly optical measurement systems. A unique self-sensing detection technique is proposed in this paper in order to address most of the limitations of the current measurement systems. A self-sensing bridge is used to excite piezoelectric MC-based sensor functioning in dynamic mode, which simultaneously measures the system’s response through the self-induced voltage generated in the piezoelectric material. As a result, the need for bulky, expensive read-out equipment is eliminated. A comprehensive mathematical model is presented for the proposed self-sensing detection platform using distributed-parameters system modeling. An adaptation strategy is then implemented in the second part in order to compensate for the time-variation of piezoelectric properties which dynamically improves the behavior of the system. Finally, results are reported from an extensive experimental investigation carried out to prove the capability of the proposed platform. Experimental results verified the proposed mathematical modeling presented in the first part of the study with accuracy of 97.48%. Implementing the adaptation strategy increased the accuracy to 99.82%. These results proved the measurement capability of the proposed self-sensing strategy. It enables development of a cost-effective, sensitive and miniaturized mass sensing platform.
Keywords: microcantilever; biosensor; distributed-parameter modeling; mass detection},
keywords = {Sensors},
pubstate = {published},
tppubtype = {article}
}
Keywords: microcantilever; biosensor; distributed-parameter modeling; mass detection
Chapman, Sandra; Dobrovolskaia, Marina; Farahani, Keyvan; Goodwin, Andrew; Joshi, Amit; Lee, Hakho; Meade, Thomas; Pomper, Martin; Ptak, Krzysztof; Rao, Jianghong; others,
Nanoparticles for cancer imaging: The good, the bad, and the promise Journal Article
In: Nano today, vol. 8, no. 5, pp. 454–460, 2013.
Abstract | BibTeX | Tags: Nanomedicine
@article{chapman2013nanoparticles,
title = {Nanoparticles for cancer imaging: The good, the bad, and the promise},
author = {Sandra Chapman and Marina Dobrovolskaia and Keyvan Farahani and Andrew Goodwin and Amit Joshi and Hakho Lee and Thomas Meade and Martin Pomper and Krzysztof Ptak and Jianghong Rao and others},
year = {2013},
date = {2013-01-01},
journal = {Nano today},
volume = {8},
number = {5},
pages = {454--460},
publisher = {Elsevier},
abstract = {Recent advances in molecular imaging and nanotechnology are providing new opportunities for biomedical imaging with great promise for the development of novel imaging agents. The unique optical, magnetic, and chemical properties of materials at the scale of nanometers allow the creation of imaging probes with better contrast enhancement, increased sensitivity, controlled biodistribution, better spatial and temporal information, multi-functionality and multi-modal imaging across MRI, PET, SPECT, and ultrasound. These features could ultimately translate to clinical advantages such as earlier detection, real time assessment of disease progression and personalized medicine. However, several years of investigation into the application of these materials to cancer research has revealed challenges that have delayed the successful application of these agents to the field of biomedical imaging. Understanding these challenges is critical to take full advantage of the benefits offered by nano-sized imaging agents. Therefore, this article presents the lessons learned and challenges encountered by a group of leading researchers in this field, and suggests ways forward to develop nanoparticle probes for cancer imaging.},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Kumar, Rajiv; Korideck, Houari; Ngwa, Wilfred; Berbeco, Ross I; Makrigiorgos, Mike G; Sridhar, Srinivas
Third generation gold nanoplatform optimized for radiation therapy Journal Article
In: Translational cancer research, vol. 2, no. 4, 2013.
Abstract | BibTeX | Tags: Nanomedicine
@article{kumar2013third,
title = {Third generation gold nanoplatform optimized for radiation therapy},
author = {Rajiv Kumar and Houari Korideck and Wilfred Ngwa and Ross I Berbeco and Mike G Makrigiorgos and Srinivas Sridhar},
year = {2013},
date = {2013-01-01},
journal = {Translational cancer research},
volume = {2},
number = {4},
publisher = {NIH Public Access},
abstract = {We report the design and fabrication of third generation ultrasmall PEGylated gold nanoparticles based platform (AuRad™) optimized for applications in radiation therapy. The AuRad™ nanoplatform has the following key features: (I) surface coating of hetero-bifunctional-PEG with amine, carboxyl, methoxy functional groups, which make this a versatile nanoplatform to conjugate various moieties like fluorophores, peptides, drugs, radiolabels; (II) size that is optimized for longer circulation, higher tumor uptake and modulated clearance; (III) high radiation enhancement. We have synthesized ultrasmall 2–3 nm gold nanoparticles, followed by attachment of hetero-bifunctional PEG and further conjugation of fluorophore AlexaFlour 647 for optical imaging, with a stability of more than 6 months. Confocal bioimaging with HeLa cells showed robust uptake of biocompatible nanoparticles in cells. Irradiation experiments X-rays showed greater than 2.8-fold cell kill enhancement as demonstrated by clonogenic survival assays. The results indicate that AuRad nanoplatform can act as potential theranostic agent in radiation therapy.
Keywords: Gold nanoparticles, PEGylation, multifunctional nanoparticles, clonogenic assay, radiation therapy},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Keywords: Gold nanoparticles, PEGylation, multifunctional nanoparticles, clonogenic assay, radiation therapy
Petrov, Yury; Sridhar, Srinivas
Electric field encephalography as a tool for functional brain research: a modeling study Journal Article
In: PloS one, vol. 8, no. 7, 2013.
Abstract | BibTeX | Tags: Nanomedicine, Neurotechnology
@article{petrov2013electric,
title = {Electric field encephalography as a tool for functional brain research: a modeling study},
author = {Yury Petrov and Srinivas Sridhar},
year = {2013},
date = {2013-01-01},
journal = {PloS one},
volume = {8},
number = {7},
publisher = {Public Library of Science},
abstract = {We introduce the notion of Electric Field Encephalography (EFEG) based on measuring electric fields of the brain and demonstrate, using computer modeling, that given the appropriate electric field sensors this technique may have significant advantages over the current EEG technique. Unlike EEG, EFEG can be used to measure brain activity in a contactless and reference-free manner at significant distances from the head surface. Principal component analysis using simulated cortical sources demonstrated that electric field sensors positioned 3 cm away from the scalp and characterized by the same signal-to-noise ratio as EEG sensors provided the same number of uncorrelated signals as scalp EEG. When positioned on the scalp, EFEG sensors provided 2–3 times more uncorrelated signals. This significant increase in the number of uncorrelated signals can be used for more accurate assessment of brain states for non-invasive brain-computer interfaces and neurofeedback applications. It also may lead to major improvements in source localization precision. Source localization simulations for the spherical and Boundary Element Method (BEM) head models demonstrated that the localization errors are reduced two-fold when using electric fields instead of electric potentials. We have identified several techniques that could be adapted for the measurement of the electric field vector required for EFEG and anticipate that this study will stimulate new experimental approaches to utilize this new tool for functional brain research.},
keywords = {Nanomedicine, Neurotechnology},
pubstate = {published},
tppubtype = {article}
}
Faegh, Samira; Jalili, Nader; Yavuzcetin, Ozgur; Nagesha, Dattatri; Kumar, Rajiv; Sridhar, Srinivas
A cost-effective self-sensing biosensor for detection of biological species at ultralow concentrations Journal Article
In: Journal of Applied Physics, vol. 113, no. 22, pp. 224905, 2013.
Abstract | BibTeX | Tags: Sensors
@article{faegh2013cost,
title = {A cost-effective self-sensing biosensor for detection of biological species at ultralow concentrations},
author = {Samira Faegh and Nader Jalili and Ozgur Yavuzcetin and Dattatri Nagesha and Rajiv Kumar and Srinivas Sridhar},
year = {2013},
date = {2013-01-01},
journal = {Journal of Applied Physics},
volume = {113},
number = {22},
pages = {224905},
publisher = {American Institute of Physics},
abstract = {Detection of ultrasmall masses and identification of biological molecules have been made possible as a result of advances in nanotechnology. Development of biosensing tools has significantly contributed to high-throughput diagnosis and analytical sensing exploiting high affinity of biomolecules. MicroCantilever (MC)-based detection has emerged as a promising biosensing tool for offering label-free and cost-effective sensing capabilities. One of the main criteria determining the success of each biosensor is the capability of the sensing platform to operate in aqueous media. Although being characterized with high sensitivity and simplicity, MCs do not provide an effective tool for measurement of marker proteins in liquid media due to large hydrodynamic damping and losses in the surrounding liquid. In this study, we describe two approaches to high sensitivity biomolecular detection using piezoelectric microcantilevers. (i) Immobilized Mass Detection in Air using electro-mechanical resonance: a unique self-sensing measurement technique is reported utilizing a self-sensing circuit consisting of a piezoelectric MC to address the mentioned limitation. The capability of the self-sensing measurement technique was first verified by detecting ultrasmall biological masses immobilized over the surface of MC by monitoring the shift in fundamental mechanical resonance frequency of the system in air and comparing it with optical-based measurement. This was further utilized for calibration of mass detection in liquid media. (ii) Immobilized Mass Detection in Liquid using the electrical self-sensing circuit's resonance: Once the capability to detect adsorbed mass was verified, the self-sensing platform was implemented to detect different concentrations of target molecule (glucose in this study) in liquid media by adopting the highly sensitive resonance frequency of the whole circuit instead of the mechanical response of MC. Molecular binding occurring over the surface of MC changes the capacitance of the total interface thus changing the resonance frequency of the circuit. The amount of shift in the measured circuit's resonance frequency provides qualitative and quantitative insight into the amount of target protein concentration. The reported diagnostic platform offers a simple, cost-effective, all-electronics method of detection where the need for any bulky, expensive optical based measurement is eliminated. Utilizing this technique, physiological concentration of glucose as low as 500 nM was measured in liquid media. This sensitivity is significantly higher than what has been previously reported using other mechanical resonance techniques.},
keywords = {Sensors},
pubstate = {published},
tppubtype = {article}
}
Ngwa, W; Korideck, H; Kumar, R; Sridhar, S; David, K; Paul, N; Berbeco, R; Cormack, R; Makrigiorgos, G
Toward Customizable Radiation Therapy Enhancement (CuRE) With Gold Nanoparticles Released, In Situ, From Gold-Loaded Brachytherapy Spacers Journal Article
In: International Journal of Radiation Oncology• Biology• Physics, vol. 87, no. 2, pp. S151, 2013.
Abstract | BibTeX | Tags: Nanomedicine
@article{ngwa2013toward,
title = {Toward Customizable Radiation Therapy Enhancement (CuRE) With Gold Nanoparticles Released, In Situ, From Gold-Loaded Brachytherapy Spacers},
author = {W Ngwa and H Korideck and R Kumar and S Sridhar and K David and N Paul and R Berbeco and R Cormack and G Makrigiorgos},
year = {2013},
date = {2013-01-01},
journal = {International Journal of Radiation Oncology• Biology• Physics},
volume = {87},
number = {2},
pages = {S151},
publisher = {Elsevier},
abstract = {Purpose/Objective(s)
Loading routinely used brachytherapy spacers with non-toxic/biocompatible gold nanoparticles (AuNP), which can be released in situ to serve as radiosensitizers is a novel potential strategy for prostate tumor sub-volume boosting or dose-painting. This study investigates the release and diffusion of the AuNP from the brachytherapy spacer in vivo using CT imaging.
Materials/Methods
Gold-loaded brachytherapy spacers (GBS) (ca. 0.8 mm x 5 mm) were produced using AuNP and biodegradable PLGA copolymer. The GBS was implanted in mice using a brachytherapy needle and CBCT-imaged over time using the small animal radiation research platform (SARRP). The CT images were exported to imageJ and the intensity of the implanted spacer evaluated at different time points. Also, to simulate a burst release of the AuNP from an implanted spacer, 20 mg Au/mL concentration of 15 nm polymer coated AuNP suspended in 20 μL phosphate-buffered saline at pH 7.4, was injected intratumorally, and the AuNP diffusion monitored via serial CT imaging over 5 time points in hours: 0.5, 48, 120, 144, and 160. The CT images were then exported to imageJ and the pixel intensities for 5 sample tumor regions of interest (at: left, right, center, anterior, posterior) extracted to assess AuNP diffusion.
Results
Results for the implanted GBS showed that the CT intensity of the spacer decreased over time, indicating the release of the AuNP as the PLGA degrades in vivo. Meanwhile, the CBCT images from the AuNP burst release study showed clear evidence of AuNP diffusion. For example, at the site of AuNP release, the CT image intensity decreased by over 160% during the investigated time range (0.5 h – 160 h). During the same time, the intensity in the tumor subvolume or ROI on the opposite side of the release site increased by over 140%. The diffusion results also showed that for the 15 nm AuNP size, potent AuNP concentrations can reside within the tumor sub-volume for a sustained period of time.
Conclusions
The results provide the first in vivo evidence of AuNP release from gold loaded brachytherapy spacers. The sustained residence of potent AuNP concentrations in the tumor sub-volume could allow for significant dose boosting during brachytherapy. Such boosting could be further customized (e.g., by varying AuNP size, functionalization, spacer degradation time, etc.) since the intra-tumor biodistribution depends on such parameters. Overall, the results provide a useful basis for future R&D towards the development of Customizable Radiation therapy Enhancement (CuRE) with AuNP for prostate cancer. Potential clinical applications for such a new approach are anticipated in salvage brachytherapy, and sub-volume radiation boosting during initial treatment to help prevent prostate cancer recurrence.},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Loading routinely used brachytherapy spacers with non-toxic/biocompatible gold nanoparticles (AuNP), which can be released in situ to serve as radiosensitizers is a novel potential strategy for prostate tumor sub-volume boosting or dose-painting. This study investigates the release and diffusion of the AuNP from the brachytherapy spacer in vivo using CT imaging.
Materials/Methods
Gold-loaded brachytherapy spacers (GBS) (ca. 0.8 mm x 5 mm) were produced using AuNP and biodegradable PLGA copolymer. The GBS was implanted in mice using a brachytherapy needle and CBCT-imaged over time using the small animal radiation research platform (SARRP). The CT images were exported to imageJ and the intensity of the implanted spacer evaluated at different time points. Also, to simulate a burst release of the AuNP from an implanted spacer, 20 mg Au/mL concentration of 15 nm polymer coated AuNP suspended in 20 μL phosphate-buffered saline at pH 7.4, was injected intratumorally, and the AuNP diffusion monitored via serial CT imaging over 5 time points in hours: 0.5, 48, 120, 144, and 160. The CT images were then exported to imageJ and the pixel intensities for 5 sample tumor regions of interest (at: left, right, center, anterior, posterior) extracted to assess AuNP diffusion.
Results
Results for the implanted GBS showed that the CT intensity of the spacer decreased over time, indicating the release of the AuNP as the PLGA degrades in vivo. Meanwhile, the CBCT images from the AuNP burst release study showed clear evidence of AuNP diffusion. For example, at the site of AuNP release, the CT image intensity decreased by over 160% during the investigated time range (0.5 h – 160 h). During the same time, the intensity in the tumor subvolume or ROI on the opposite side of the release site increased by over 140%. The diffusion results also showed that for the 15 nm AuNP size, potent AuNP concentrations can reside within the tumor sub-volume for a sustained period of time.
Conclusions
The results provide the first in vivo evidence of AuNP release from gold loaded brachytherapy spacers. The sustained residence of potent AuNP concentrations in the tumor sub-volume could allow for significant dose boosting during brachytherapy. Such boosting could be further customized (e.g., by varying AuNP size, functionalization, spacer degradation time, etc.) since the intra-tumor biodistribution depends on such parameters. Overall, the results provide a useful basis for future R&D towards the development of Customizable Radiation therapy Enhancement (CuRE) with AuNP for prostate cancer. Potential clinical applications for such a new approach are anticipated in salvage brachytherapy, and sub-volume radiation boosting during initial treatment to help prevent prostate cancer recurrence.
Tangutoori, Shifalika; Korideck, Houari; Makrigiorgos, Mike; Cormack, Robert; Sridhar, Srinivas
Abstract A81: A novel nano-formulation for systemic administration of PARPi-olaparib (Nano-Olaparib) for radiosensitization, chemosensitization, and combinatorial therapy in prostate cancer. Miscellaneous
2013.
BibTeX | Tags: Nanomedicine
@misc{tangutoori2013abstract,
title = {Abstract A81: A novel nano-formulation for systemic administration of PARPi-olaparib (Nano-Olaparib) for radiosensitization, chemosensitization, and combinatorial therapy in prostate cancer.},
author = {Shifalika Tangutoori and Houari Korideck and Mike Makrigiorgos and Robert Cormack and Srinivas Sridhar},
year = {2013},
date = {2013-01-01},
publisher = {American Association for Cancer Research},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {misc}
}
Kumar, Rajiv; Kulkarni, Apurva; Nabulsi, Jude; Nagesha, Dattatri K; Cormack, Robert; Makrigiorgos, Mike G; Sridhar, Srinivas
Facile synthesis of PEGylated PLGA nanoparticles encapsulating doxorubicin and its in vitro evaluation as potent drug delivery vehicle Journal Article
In: Drug delivery and translational research, vol. 3, no. 4, pp. 299–308, 2013.
Abstract | BibTeX | Tags: Nanomedicine
@article{kumar2013facile,
title = {Facile synthesis of PEGylated PLGA nanoparticles encapsulating doxorubicin and its in vitro evaluation as potent drug delivery vehicle},
author = {Rajiv Kumar and Apurva Kulkarni and Jude Nabulsi and Dattatri K Nagesha and Robert Cormack and Mike G Makrigiorgos and Srinivas Sridhar},
year = {2013},
date = {2013-01-01},
journal = {Drug delivery and translational research},
volume = {3},
number = {4},
pages = {299--308},
publisher = {Springer US},
abstract = {The advent of nanotechnology has bolstered a variety of nanoparticle-based platforms for different biomedical applications. A better understanding for engineering novel nanoparticles for applications in cancer staging and therapy requires careful assessment of the nanoparticle’s physico-chemical properties. Herein we report a facile synthesis method for PEGylated PLGA nanoparticles encapsulating anti-cancer drug doxorubicin for cancer imaging and therapy. The simple nanoprecipitation method reported here resulted in very robust PEGylated PLGA nanoparticles with close to 95 % drug encapsulation efficiency. The nanoparticles showed a size of ~110 nm as characterized by TEM and DLS. The nanoparticles were further characterized by optical UV–Visible and fluorescence spectroscopy. The encapsulated doxorubicin showed a sustained release (>80 %) from the nanoparticles matrix over a period of 8 days. The drug delivery efficiency of the nanoparticles was confirmed in vitro confocal imaging with PC3 and HeLa cell lines. In vitro quantitative estimation of drug accumulation in PC3 cell line showed a 22 times higher concentration of drug in case of nanoparticle-based formulation in comparison to free drug and this was further reflected in the in vitro cytotoxicity assays. Overall the synthesis method reported here provides a simple and robust PLGA-based platform for efficient drug delivery and imaging of cancer cells in vitro and in vivo.
},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Teh, James L; Hanson, Robert N; Sridhar, Srinivas
Synthesis and characterization of Arg-Gly-Asp (RGD) peptidomimetics functionalized onto gold nanoparticles Proceedings Article
In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC 1155 16TH ST, NW, WASHINGTON, DC 20036 USA 2013.
BibTeX | Tags: Nanomedicine
@inproceedings{teh2013synthesis,
title = {Synthesis and characterization of Arg-Gly-Asp (RGD) peptidomimetics functionalized onto gold nanoparticles},
author = {James L Teh and Robert N Hanson and Srinivas Sridhar},
year = {2013},
date = {2013-01-01},
booktitle = {ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY},
volume = {245},
organization = {AMER CHEMICAL SOC 1155 16TH ST, NW, WASHINGTON, DC 20036 USA},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {inproceedings}
}
Kumar, Rajiv; Belz, Jodi; Markovic, Stacey; Jadhav, Tej; Nguyen, Paul; Niedre, Mark; DAmico, Anthony; Makrigiorgos, Mike; Cormack, Robert; Sridhar, Srinivas
Sustained release of drug eluting nanoparticles from implantable devices for loco-regional chemoradiation therapy. Miscellaneous
2013.
Abstract | BibTeX | Tags: Nanomedicine
@misc{kumar2013sustained,
title = {Sustained release of drug eluting nanoparticles from implantable devices for loco-regional chemoradiation therapy.},
author = {Rajiv Kumar and Jodi Belz and Stacey Markovic and Tej Jadhav and Paul Nguyen and Mark Niedre and Anthony DAmico and Mike Makrigiorgos and Robert Cormack and Srinivas Sridhar},
year = {2013},
date = {2013-01-01},
publisher = {American Association for Cancer Research},
abstract = {Systemic chemotherapy is often used with radiation therapy in the management of prostate, cervix and lung cancer patients, but leads to severe systemic toxicities. We have introduced a new modality of loco-regional chemoradiation therapy termed in-situ image guided radiation therapy (BIS-IGRT) that offers the potential to deliver planned, localized and sustained delivery of chemotherapy agent, without systemic toxicities, as part of routine minimally invasive image guided radiation therapy procedures. Such image guided chemoradiation therapy requires characterization of the drug distribution produced by implantable drug eluters. This work presents imaging based means to measure temporal and spatial properties of diffusion distributions around spacers coated with dye-loaded nanoparticles.
The distribution of 250nm silica nanoparticles (NP) conjugated to Cyanine 7.5 dye was evaluated with a custom built high-speed near-infrared small animal imaging platform providing 0.1 millimeter spatial resolution with >1Hz image acquisition rate. A brachytherapy spacer loaded with the Cy7.5/silica NP was injected subcutaneously on the left hind flank of a mouse and one was inserted into a xenograft tumor on the opposite flank as part of an approved animal research protocol. The mouse was imaged more than 36 days.
The in vivo imaging experiments show that the area of high signal increases with time suggesting that NP accumulate in the vicinity of a spacer without diffusing to the rest of the body. The spatial and temporal characteristics of NP accumulation indicate that a BIS-IGRT approach may provide an effective means to improve the therapeutic ratio of brachytherapy.
Conclusion: In-vivo measurements demonstrate that NP remain resident in the vicinity of the implanted eluting spacers with accumulation over times appropriate to improve brachytherapy's therapeutic ratio. Future work will optimize the NP and substrate properties of an implantable spacer to attain the optimal chemotherapy distributions for simultaneous placement during image guided brachytherapy implants.
We acknowledge partial support from NSF DGE 0965843 and HHS/5U54CA151881-02.
Citation Format: Rajiv Kumar, Jodi Belz, Stacey Markovic, Tej Jadhav, Paul Nguyen, Mark Niedre, Anthony DAmico, Mike Makrigiorgos, Robert Cormack, Srinivas Sridhar. Sustained release of drug eluting nanoparticles from implantable devices for loco-regional chemoradiation therapy. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1594. doi:10.1158/1538-7445.AM2013-1594
©2013 American Association for Cancer Research},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {misc}
}
The distribution of 250nm silica nanoparticles (NP) conjugated to Cyanine 7.5 dye was evaluated with a custom built high-speed near-infrared small animal imaging platform providing 0.1 millimeter spatial resolution with >1Hz image acquisition rate. A brachytherapy spacer loaded with the Cy7.5/silica NP was injected subcutaneously on the left hind flank of a mouse and one was inserted into a xenograft tumor on the opposite flank as part of an approved animal research protocol. The mouse was imaged more than 36 days.
The in vivo imaging experiments show that the area of high signal increases with time suggesting that NP accumulate in the vicinity of a spacer without diffusing to the rest of the body. The spatial and temporal characteristics of NP accumulation indicate that a BIS-IGRT approach may provide an effective means to improve the therapeutic ratio of brachytherapy.
Conclusion: In-vivo measurements demonstrate that NP remain resident in the vicinity of the implanted eluting spacers with accumulation over times appropriate to improve brachytherapy's therapeutic ratio. Future work will optimize the NP and substrate properties of an implantable spacer to attain the optimal chemotherapy distributions for simultaneous placement during image guided brachytherapy implants.
We acknowledge partial support from NSF DGE 0965843 and HHS/5U54CA151881-02.
Citation Format: Rajiv Kumar, Jodi Belz, Stacey Markovic, Tej Jadhav, Paul Nguyen, Mark Niedre, Anthony DAmico, Mike Makrigiorgos, Robert Cormack, Srinivas Sridhar. Sustained release of drug eluting nanoparticles from implantable devices for loco-regional chemoradiation therapy. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1594. doi:10.1158/1538-7445.AM2013-1594
©2013 American Association for Cancer Research
Kumar, Rajiv; Belz, Jodi E; Markovic, Stacey; Korideck, Houari; Ngwa, Wilfred F; Niedre, Mark; Berbeco, Ross I; Cormack, Robert; Makrigiorgos, Mike G; Sridhar, Srinivas
Abstract A82: Localized tumor delivery of radiosensitizers and chemotherapeutics using ‘INCeRT’implants. Miscellaneous
2013.
Abstract | BibTeX | Tags: Nanomedicine
@misc{kumar2013abstract,
title = {Abstract A82: Localized tumor delivery of radiosensitizers and chemotherapeutics using ‘INCeRT’implants.},
author = {Rajiv Kumar and Jodi E Belz and Stacey Markovic and Houari Korideck and Wilfred F Ngwa and Mark Niedre and Ross I Berbeco and Robert Cormack and Mike G Makrigiorgos and Srinivas Sridhar},
year = {2013},
date = {2013-01-01},
publisher = {American Association for Cancer Research},
abstract = {In cancer therapy, effective delivery of the therapeutic plays a critical role in determining the success of the treatment planning system. In last decade, there is a major thrust in developing novel nanoparticles based delivery systems to improve the therapeutic benefits in cancer. An efficient delivery system should be able to target the diseased site with minimal systemic toxicity and a slow sustained release of the drug. Here, we have fabricated a nanoparticles based smart ‘INCeRT’ (Implantable Nanoplatform for Chemo-Radiation Therapy) implant for localized delivery of radiosensitizing nanoparticles/ drugs in prostate cancer in conjunction with brachytherapy. These implants are physically similar to the clinically used brachytherapy spacers but have the added capability of imaging and local drug delivery. We have fabricated INCeRT spacers with biocompatible and biodegradable polymer, PLGA (poly-(lactide-co-glycolide)) impregnated with nanoparticles encapsulating imaging probe (Cyanine 7.5) and chemotherapeutic drug, docetaxel (DTX). Using a similar approach, we have also fabricated PLGA spacers impregnated with high Z (atomic number) gold nanoparticles (Hi-Z-CuRE: High Z-Customizable Radiotherapy Enhancement) for effectively boosting the radiation dose locally. The morphology, composition and nanoparticle's distribution inside the spacers was studied by SEM (scanning electron microscopy) and EDS (Energy-dispersive X-ray spectroscopy). Further, preliminary in vivo imaging experiments with subcutaneous prostate cancer tumored mice implanted with INCeRT spacers showed a size dependent diffusion of nanoparticles from the spacers in the tumor matrix. Also, from in vivo therapeutic studies with these spacers showed a sustained and slow release of the DTX from the spacers and showed a better response in suppressing the tumor as opposed control mice with saline injections. Further experiments for studying the combined chemo-radiation therapy are underway. This new treatment approach would be of crucial benefit for patients with local relapse who require salvage radiotherapy but have reached their radiotherapy normal tissue dose limits. This work was supported partially by NSF-DGE-0965843, HHS/1U54CA151881 CORE1, 1R03 CA164645-01 and a seed grant from the BWH Biomedical Research Institute.
Citation Information: Mol Cancer Ther 2013;12(11 Suppl):A82.
Citation Format: Rajiv Kumar, Jodi E. Belz, Stacey Markovic, Houari Korideck, Wilfred F. Ngwa, Mark Niedre, Ross I. Berbeco, Robert Cormack, Mike G. Makrigiorgos, Srinivas Sridhar. Localized tumor delivery of radiosensitizers and chemotherapeutics using ‘INCeRT’ implants. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr A82.
Copyright © November 2013, American Association for Cancer Research},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {misc}
}
Citation Information: Mol Cancer Ther 2013;12(11 Suppl):A82.
Citation Format: Rajiv Kumar, Jodi E. Belz, Stacey Markovic, Houari Korideck, Wilfred F. Ngwa, Mark Niedre, Ross I. Berbeco, Robert Cormack, Mike G. Makrigiorgos, Srinivas Sridhar. Localized tumor delivery of radiosensitizers and chemotherapeutics using ‘INCeRT’ implants. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr A82.
Copyright © November 2013, American Association for Cancer Research
Sridhar, Srinivas; Dokmeci, Mehmet; Mosallaei, Hossein; Menon, Latika; Sokoloff, Jeffrey; Heiman, Don
Metamaterials and Conformal Antenna Technologies Technical Report
DTIC Document 2013.
Abstract | BibTeX | Tags: Metamaterials and Nanophotonics
@techreport{sridhar2013metamaterials,
title = {Metamaterials and Conformal Antenna Technologies},
author = {Srinivas Sridhar and Mehmet Dokmeci and Hossein Mosallaei and Latika Menon and Jeffrey Sokoloff and Don Heiman},
year = {2013},
date = {2013-01-01},
institution = {DTIC Document},
abstract = {Meta-materials are artificially constructed materials. When electromagnetic waves propagate
through meta-materials they display properties different from those found in natural materials.
These different properties can include negative refraction (light is bent in the opposite direction
from that expected from general laws of physics), flat lens focusing and sub-wavelength
imaging. The use of meta-materials to direct electromagnetic beams is a highly promising
approach to overcome current limitations of conformal antennas by improving the radiation
characteristics of antenna elements, especially those at the edge of phased array antennas.
This project was centered on research and development of next generation metamaterials that are
needed in optical and microwave radar antenna technologies. By directing electromagnetic
beams, such materials can enormously improve detection the detection of enemy bodies and
satellite communication with aircraft.
During this performance period, groundbreaking results were obtained in the following areas:
• Metamaterial Optical Components
• Theory of metamaterials based optical components
• Metamaterials, Nanofabrication and Sensors
• Metamaterial Antennas
• Reviews
Our work in this area has led to several major results, reported in 26 completed papers, and 3
patent applications, resulted in several invited and contributed presentations at international
conferences and workshops, and has received extensive attention in the popular press, including
write-ups in Nature, R&D Magazine, and other web and print outlets. },
keywords = {Metamaterials and Nanophotonics},
pubstate = {published},
tppubtype = {techreport}
}
through meta-materials they display properties different from those found in natural materials.
These different properties can include negative refraction (light is bent in the opposite direction
from that expected from general laws of physics), flat lens focusing and sub-wavelength
imaging. The use of meta-materials to direct electromagnetic beams is a highly promising
approach to overcome current limitations of conformal antennas by improving the radiation
characteristics of antenna elements, especially those at the edge of phased array antennas.
This project was centered on research and development of next generation metamaterials that are
needed in optical and microwave radar antenna technologies. By directing electromagnetic
beams, such materials can enormously improve detection the detection of enemy bodies and
satellite communication with aircraft.
During this performance period, groundbreaking results were obtained in the following areas:
• Metamaterial Optical Components
• Theory of metamaterials based optical components
• Metamaterials, Nanofabrication and Sensors
• Metamaterial Antennas
• Reviews
Our work in this area has led to several major results, reported in 26 completed papers, and 3
patent applications, resulted in several invited and contributed presentations at international
conferences and workshops, and has received extensive attention in the popular press, including
write-ups in Nature, R&D Magazine, and other web and print outlets.
Campbell, Robert B; Sridhar, Srinivas
Magnetic nanoplatforms for theranostic and multi-modal imaging applications Miscellaneous
2013, (US Patent App. 13/583,616).
Abstract | BibTeX | Tags: Nanomedicine
@misc{campbell2013magnetic,
title = {Magnetic nanoplatforms for theranostic and multi-modal imaging applications},
author = {Robert B Campbell and Srinivas Sridhar},
year = {2013},
date = {2013-01-01},
abstract = {Disclosed are nanoparticle compositions comprising paramagnetic particles, radiolabels, fluorophores, and/or positron emission tomography agents encapsulated within a biocompatible vehicle. In addition, methods of multi-modal diagnostic imaging and treating diseased tissues are disclosed, wherein the methods comprises administering a nanoparticle composition to a subject in which the nanoparticle composition comprises paramagnetic particles, radiolabels, fluorophores, and positron emission tomography agents encapsulated within a biocompatible vehicle.},
note = {US Patent App. 13/583,616},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {misc}
}
2012
Anderson, D; Archakov, A; Avgoustakis, K; Baumgartner, A; Bawa, R; Bernardo, M; Biricova, V; Brayner, R; Brechbiel, MW; Buse, J; others,
Our thanks to all those who have helped with this issue of Nanomedicine. Listed below are authors, referees and others who have kindly given their time, effort and expertise; their generosity has helped establish this publication. Journal Article
In: 2012.
BibTeX | Tags: Nanomedicine
@article{andersonour,
title = {Our thanks to all those who have helped with this issue of Nanomedicine. Listed below are authors, referees and others who have kindly given their time, effort and expertise; their generosity has helped establish this publication.},
author = {D Anderson and A Archakov and K Avgoustakis and A Baumgartner and R Bawa and M Bernardo and V Biricova and R Brayner and MW Brechbiel and J Buse and others},
year = {2012},
date = {2012-12-20},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Kumar, Rajiv; Patel, Janki; Korideck, Houari; Berbeco, Ross I; Makrigiorgos, Mike G; Sridhar, Srinivas
Comprehensive evaluation of PEGylated gold nanorods for two photon photoluminescence image guided radiation therapy enhancement Miscellaneous
2012.
Abstract | BibTeX | Tags: Nanomedicine
@misc{kumar2012comprehensive,
title = {Comprehensive evaluation of PEGylated gold nanorods for two photon photoluminescence image guided radiation therapy enhancement},
author = {Rajiv Kumar and Janki Patel and Houari Korideck and Ross I Berbeco and Mike G Makrigiorgos and Srinivas Sridhar},
year = {2012},
date = {2012-01-01},
publisher = {American Association for Cancer Research},
abstract = {Nanoparticle formulations of gold have shown a tremendous potential in various biomedical applications. The use of high atomic number (Z) materials presents an attractive approach in enhancing the therapeutic efficacy of the radiation therapy. The high Z number for gold (Z=79) makes them an ideal candidate for radiosensitization enhancement. The ability of the anisotropic gold nanorods to sustain the resonating surface plasmon with minimal damping results in highly efficient two-photon induced photoluminescence imaging. Here we present the synthesis and in vitro characterization of PEGylated gold nanorods as efficient radiosensitizing agents which can be imaged using inherent two-photon photoluminescence without a conjugated fluorophore. We have synthesized gold nanorods with an aspect ratio of 2.5 and functionalized the surface with different ratios of methoxy and amine PEG for modulating the charge and imparting the functional groups. The cellular uptake behavior in prostate cancer cell line PC3 was studied and the results indicated a robust uptake of the amine functionalized nanorods. The quantitative estimation of the nanorods uptake was performed with BCA assay as amount of nanorods present in per microgram of protein. Two photon photoluminescence imaging also confirmed a robust cellular uptake of the amine functionalized nanorods. The radiation damage enhancement of the gold nanorods was confirmed using PC3 cells. The cells treated with gold nanorods were irradiated with kilovoltage X-rays. A γH2AX assay was used for quantitation of the DNA damage with and without nanorods as controls. The results indicated an increased highly efficient DNA damage in cells treated with gold nanorods. The outcome of this research will enable further application of targeted nanorods in advanced animal models as efficient radiation dose enhancement agents wherein two-photon photoluminescence imaging will provide a real time assessment of the therapeutic response and disease progression.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1472. doi:1538-7445.AM2012-1472
©2012 American Association for Cancer Research},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {misc}
}
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1472. doi:1538-7445.AM2012-1472
©2012 American Association for Cancer Research
Kumar, Rajiv; Kulkarni, Apurva; Nagesha, Dattatri; Cormack, Robert; Makrigiorgos, Mike; Sridhar, Srinivas
Nanocoated brachytherapy spacers eluting radiosensitizers for biological in situ image-guided radiation therapy of prostate cancer Miscellaneous
2012.
Abstract | BibTeX | Tags: Nanomedicine
@misc{kumar2012nanocoated,
title = {Nanocoated brachytherapy spacers eluting radiosensitizers for biological in situ image-guided radiation therapy of prostate cancer},
author = {Rajiv Kumar and Apurva Kulkarni and Dattatri Nagesha and Robert Cormack and Mike Makrigiorgos and Srinivas Sridhar},
year = {2012},
date = {2012-01-01},
publisher = {American Association for Cancer Research},
abstract = {The overall goal of this project is to develop means to locally radio-sensitize the prostate to enable prostate cancer (PCa) cure with the use of lower radiation doses, thereby leading to less rectal toxicity. This new approach for chemoradiation therapy (CRT), termed Biological In-Situ Image Guided Radiation Therapy BIS-IGRT, involves the coating of spacers routinely used during prostate I-125-based brachytherapy with radiosensitizing drugs (e.g. docetaxel DTX for PCa). This approach provides localized in-situ delivery of the sensitizer to the tumor and avoids the toxicity associated with current systemic delivery of radiosensitizers. BIS-IGRT adds radiosensitization capability to the standard brachytherapy procedure and with minimal additional inconvenience to the patient. Current CRT with adjuvant systemic chemotherapy does not provide the sustained delivery and drug concentration needed for efficient radiosensitization. Thereby BIS-IGRT improves the therapeutic ratio of radiation therapy without introducing additional patient interventions over current brachytherapy procedures. We have established the following: 1. We have shown through modeling that drug distributions can be achieved that can lead to increased efficiency of image-guided brachytherapy (drug-coated spacers) or image guided external beam therapy (drug-coated fiducials). 2. Doxorubicine-coated fiducials (Dox/PLGA-PEG/CHIT) show release characteristics over 40 days in aqueous media, which is tailored to the time scales required for BIS-IGRT. The cytotoxicity of Dox/ PLGA-PEG NP is comparable to that of free Dox, so that there is no reduction of activity upon encapsulation in the NP. 3. Localized bolus injection of dye-loaded PLGA-PEG nanoparticles (NPs) distributes within 24 hours throughout the tumor, indicating that the sustained release from coated brachytherapy spacers has the potential to achieve the desired biological dose-painting of the tumor. BIS-IGRT could proffer radiation oncologists and medical physicists with a new treatment option for substantially enhancing therapeutic ratio and boosting cure rate for the hundreds of thousands of Americans diagnosed with prostate cancer each year. This new treatment approach would be of crucial benefit for patients with local relapse who require salvage radiotherapy but have reached their radiotherapy normal tissue dose limits. BIS-IGRT can still be accompanied by IV administration of chemotherapeutics, particularly for micro-metastasis, so that existing therapeutic approaches are not compromised. In addition BIS-IGRT could potentially become a mainstream treatment for patients newly diagnosed with prostate or other cancers, where radiation therapy is a common treatment modality.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1473. doi:1538-7445.AM2012-1473
©2012 American Association for Cancer Research},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {misc}
}
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1473. doi:1538-7445.AM2012-1473
©2012 American Association for Cancer Research
Kumar, Rajiv; Kulkarni, Apurva; Nagesha, Dattatri K; Sridhar, Srinivas
In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer Journal Article
In: Theranostics, vol. 2, no. 7, pp. 714, 2012.
Abstract | BibTeX | Tags: Nanomedicine
@article{kumar2012vitro,
title = {In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer},
author = {Rajiv Kumar and Apurva Kulkarni and Dattatri K Nagesha and Srinivas Sridhar},
year = {2012},
date = {2012-01-01},
journal = {Theranostics},
volume = {2},
number = {7},
pages = {714},
publisher = {Ivyspring International Publisher},
abstract = {We describe the synthesis and application of theranostic phospholipid based polymeric micelles for optical fluorescence imaging and controlled drug delivery. A sustained release of the drug was observed from the co-encapsulated micellar formulation. In vitro optical fluorescence imaging and cytotoxicity studies with HeLa cell line demonstrated the potential of these micellar systems as efficient optical imaging and therapeutic probes.
For the past decade engineered nanoplatforms have seen a momentous progress in developing a multimodal theranostic formulation which can be simultaneously used for imaging and therapy. In this report we describe the synthesis and application of theranostic phospholipid based polymeric micelles for optical fluorescence imaging and controlled drug delivery. CdSe quantum dots (QDs) and anti-cancer drug, doxorubicin (Dox), were co-encapsulated into the hydrophobic core of the micelles. The micelles are characterized using optical spectroscopy for characteristic absorbance and fluorescence features of QDs and Dox. TEM and DLS studies yielded a size of <50 nm for the micellar formulations with very narrow size distribution. A sustained release of the drug was observed from the co-encapsulated micellar formulation. In vitro optical fluorescence imaging and cytotoxicity studies with HeLa cell line demonstrated the potential of these micellar systems as efficient optical imaging and therapeutic probes.
Keywords: Theranostic Polymeric Micelles, Imaging, Drug Delivery, Cancer
},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
For the past decade engineered nanoplatforms have seen a momentous progress in developing a multimodal theranostic formulation which can be simultaneously used for imaging and therapy. In this report we describe the synthesis and application of theranostic phospholipid based polymeric micelles for optical fluorescence imaging and controlled drug delivery. CdSe quantum dots (QDs) and anti-cancer drug, doxorubicin (Dox), were co-encapsulated into the hydrophobic core of the micelles. The micelles are characterized using optical spectroscopy for characteristic absorbance and fluorescence features of QDs and Dox. TEM and DLS studies yielded a size of <50 nm for the micellar formulations with very narrow size distribution. A sustained release of the drug was observed from the co-encapsulated micellar formulation. In vitro optical fluorescence imaging and cytotoxicity studies with HeLa cell line demonstrated the potential of these micellar systems as efficient optical imaging and therapeutic probes.
Keywords: Theranostic Polymeric Micelles, Imaging, Drug Delivery, Cancer
Berbeco, Ross I; Korideck, Houari; Ngwa, Wilfred; Kumar, Rajiv; Patel, Janki; Sridhar, Srinivas; Johnson, Sarah; Price, Brendan D; Kimmelman, Alec; Makrigiorgos, Mike G
DNA damage enhancement from gold nanoparticles for clinical MV photon beams Journal Article
In: Radiation research, vol. 178, no. 6, pp. 604–608, 2012.
Abstract | BibTeX | Tags: Nanomedicine
@article{berbeco2012dna,
title = {DNA damage enhancement from gold nanoparticles for clinical MV photon beams},
author = {Ross I Berbeco and Houari Korideck and Wilfred Ngwa and Rajiv Kumar and Janki Patel and Srinivas Sridhar and Sarah Johnson and Brendan D Price and Alec Kimmelman and Mike G Makrigiorgos},
year = {2012},
date = {2012-01-01},
journal = {Radiation research},
volume = {178},
number = {6},
pages = {604--608},
publisher = {The Radiation Research Society},
abstract = {OTHER| NOVEMBER 13 2012
DNA Damage Enhancement from Gold Nanoparticles for Clinical MV Photon Beams
Ross I. Berbeco; Houari Korideck; Wilfred Ngwa; Rajiv Kumar; Janki Patel; Srinivas Sridhar; Sarah Johnson; Brendan D. Price; Alec Kimmelman; G. Mike Makrigiorgos
Radiat Res (2012) 178 (6): 604–608.
https://doi.org/10.1667/RR3001.1
Share Icon
Share
Tools Icon
Tools
Search Site
In this study, we quantify the relative damage enhancement due to the presence of gold nanoparticles (GNP) in vitro in a clinical 6 MV beam for various delivery parameters and depths. It is expected that depths and delivery modes that produce a larger proportions of low-energy photons will have a larger effect on the cell samples containing GNP. HeLa cells with and without 50 nm GNP were irradiated at depths of 1.5, 5, 10, 15 and 20 cm. Conventional beams with square aperture sizes 5, 10 and 15 cm at isocenter, and flattening filter free (FFF) beams were used. Relative DNA damage enhancement with GNP was evaluated by γ-H2AX staining. Statistically significant increases in DNA damage with GNP, compared to the absence of GNP, were observed for all depths and delivery modes. Relative to the shallowest depth, damage enhancement was observed to increase as a function of increasing depth for all deliveries. For the conventional (open field) delivery, DNA damage enhancement with GNP was seen to increase as a function of field size. For FFF delivery, a substantial increase in enhancement was found relative to the conventional field delivery. The measured relative DNA damage enhancement validates the theoretically predicted trends as a function of depth and delivery mode for clinical MV photon beams. The results of this study open new possibilities for the clinical development of gold nanoparticle-aided radiation therapy.},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
DNA Damage Enhancement from Gold Nanoparticles for Clinical MV Photon Beams
Ross I. Berbeco; Houari Korideck; Wilfred Ngwa; Rajiv Kumar; Janki Patel; Srinivas Sridhar; Sarah Johnson; Brendan D. Price; Alec Kimmelman; G. Mike Makrigiorgos
Radiat Res (2012) 178 (6): 604–608.
https://doi.org/10.1667/RR3001.1
Share Icon
Share
Tools Icon
Tools
Search Site
In this study, we quantify the relative damage enhancement due to the presence of gold nanoparticles (GNP) in vitro in a clinical 6 MV beam for various delivery parameters and depths. It is expected that depths and delivery modes that produce a larger proportions of low-energy photons will have a larger effect on the cell samples containing GNP. HeLa cells with and without 50 nm GNP were irradiated at depths of 1.5, 5, 10, 15 and 20 cm. Conventional beams with square aperture sizes 5, 10 and 15 cm at isocenter, and flattening filter free (FFF) beams were used. Relative DNA damage enhancement with GNP was evaluated by γ-H2AX staining. Statistically significant increases in DNA damage with GNP, compared to the absence of GNP, were observed for all depths and delivery modes. Relative to the shallowest depth, damage enhancement was observed to increase as a function of increasing depth for all deliveries. For the conventional (open field) delivery, DNA damage enhancement with GNP was seen to increase as a function of field size. For FFF delivery, a substantial increase in enhancement was found relative to the conventional field delivery. The measured relative DNA damage enhancement validates the theoretically predicted trends as a function of depth and delivery mode for clinical MV photon beams. The results of this study open new possibilities for the clinical development of gold nanoparticle-aided radiation therapy.
Yavuzcetin, Ozgur; Novikov, Herman P; Dally, Rebecca L; Malley, Sean T; Perry, Nicholas R; Ozturk, Birol; Sridhar, Srinivas
Photonic crystal fabrication in lithium niobate via pattern transfer through wet and dry etched chromium mask Journal Article
In: Journal of Applied Physics, vol. 112, no. 7, pp. 074303, 2012.
Abstract | BibTeX | Tags: Sensors
@article{yavuzcetin2012photonic,
title = {Photonic crystal fabrication in lithium niobate via pattern transfer through wet and dry etched chromium mask},
author = {Ozgur Yavuzcetin and Herman P Novikov and Rebecca L Dally and Sean T Malley and Nicholas R Perry and Birol Ozturk and Srinivas Sridhar},
year = {2012},
date = {2012-01-01},
journal = {Journal of Applied Physics},
volume = {112},
number = {7},
pages = {074303},
publisher = {American Institute of Physics},
abstract = {The need to fabricate photonic crystals from lithium niobate (LN) with accurate feature sizes is important to the development of optoelectronic devices. This paper reports a fabrication process to dry etch X-cut LN at a submicron scale using electron beam lithography and chromium as a hard mask. The chromium mask was used for both dry-etching and wet-etching in a unique method. Problems and solutions found during fabrication are presented. Arrays consisting of 400 nm diameter holes with a high aspect ratio were etched in LN, creating photonic crystals modeled to transmit light in the infrared spectrum.},
keywords = {Sensors},
pubstate = {published},
tppubtype = {article}
}
Berbeco, R; Korideck, H; Ngwa, W; Kumar, R; Patel, J; Sridhar, S; Johnson, S; Price, B; Kimmelman, A; Makrigiorgos, M
TU-C-BRB-11: In Vitro Dose Enhancement from Gold Nanoparticles under Different Clinical MV Photon Beam Configurations Journal Article
In: Medical Physics, vol. 39, no. 6Part23, pp. 3900–3901, 2012.
BibTeX | Tags: Nanomedicine
@article{berbeco2012tu,
title = {TU-C-BRB-11: In Vitro Dose Enhancement from Gold Nanoparticles under Different Clinical MV Photon Beam Configurations},
author = {R Berbeco and H Korideck and W Ngwa and R Kumar and J Patel and S Sridhar and S Johnson and B Price and A Kimmelman and M Makrigiorgos},
year = {2012},
date = {2012-01-01},
journal = {Medical Physics},
volume = {39},
number = {6Part23},
pages = {3900--3901},
publisher = {American Association of Physicists in Medicine},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Ngwa, W; Korideck, H; Kimmelman, A; Kassis, AI; Kumar, R; Sridhar, S; Makrigiorgos, M; Cormack, RA
In vitro dose enhancement from gold nanoparticles during low-dose-rate gamma irradiation with I-125 brachytherapy seeds Journal Article
In: International Journal of Radiation Oncology• Biology• Physics, vol. 84, no. 3, pp. S134, 2012.
Abstract | BibTeX | Tags: Nanomedicine
@article{ngwa2012vitro,
title = {In vitro dose enhancement from gold nanoparticles during low-dose-rate gamma irradiation with I-125 brachytherapy seeds},
author = {W Ngwa and H Korideck and A Kimmelman and AI Kassis and R Kumar and S Sridhar and M Makrigiorgos and RA Cormack},
year = {2012},
date = {2012-01-01},
journal = {International Journal of Radiation Oncology• Biology• Physics},
volume = {84},
number = {3},
pages = {S134},
publisher = {Elsevier},
abstract = {Purpose/Objective(s)
Recent studies have predicted substantial dose enhancement to tumors when gold nanoparticles (AuNP) are employed as adjuvants to radiation therapy at kV energies. Because the enhancement results from processes at kV energies, some studies proposed gold nanoparticle-aided brachytherapy as a radiation therapy approach with potential to meet technical and clinical requirements for implementation. To the best of our knowledge, there has been no study providing clear experimental evidence to corroborate the substantial dose enhancement predictions when irradiating with low dose rate gamma photons from brachytherapy sources. This study investigates the in vitro dose enhancement of AuNP during irradiation of cancer cells by I-125 low dose rate brachytherapy sources.
Materials/Methods
HeLa cell cultures were incubated with and without gold nanoparticles (AuNP) in alternate wells of an 8 well-chamber slide; 4 wells on each slide had cell cultures with AuNP while 4 wells contained cell cultures with no AuNP. Two slides were prepared for each experiment: one slide to be irradiated while the other serves as sham-irradiation control. The cells were irradiated with gamma photons from I-125 brachytherapy seeds in a plaque contained in a custom-built irradiation jig. The plaque was designed to achieve a relatively homogeneous dose distribution in the plane of the cell culture slide. Four sets of irradiation experiments were conducted at 370C at dose rates ranging from 2.1 cGy/hr to 4.5 cGy/hr. The dose rates were varied by varying the height of the cell culture slide above the plaque containing the I-125 seeds. Residual gammaH2AX was measured 24 hours after irradiation and used to compare the dose response of the cells with and without AuNP. In addition, the relative dose enhancement factor (DEF), representing the ratio of the dose to the cells with and without the presence of AuNP, was estimated from the data.
Results
From the dose response behavior, the results show that the biologic effect when irradiating with 0.2 mg/mL concentration of AuNP is up to 2.3 times greater than without AuNP. This major increase in radiation damage to cancer cells incubated with AuNP corresponds to an estimated DEF of over 3.5.
Conclusions
Our findings provide the first experimental evidence of substantial dose enhancement from gold nanoparticles during low dose rate gamma irradiation from brachytherapy sources. These in vitro study results provide impetus for further preclinical and clinical investigations in the development of gold nanoparticle-aided brachytherapy.},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Recent studies have predicted substantial dose enhancement to tumors when gold nanoparticles (AuNP) are employed as adjuvants to radiation therapy at kV energies. Because the enhancement results from processes at kV energies, some studies proposed gold nanoparticle-aided brachytherapy as a radiation therapy approach with potential to meet technical and clinical requirements for implementation. To the best of our knowledge, there has been no study providing clear experimental evidence to corroborate the substantial dose enhancement predictions when irradiating with low dose rate gamma photons from brachytherapy sources. This study investigates the in vitro dose enhancement of AuNP during irradiation of cancer cells by I-125 low dose rate brachytherapy sources.
Materials/Methods
HeLa cell cultures were incubated with and without gold nanoparticles (AuNP) in alternate wells of an 8 well-chamber slide; 4 wells on each slide had cell cultures with AuNP while 4 wells contained cell cultures with no AuNP. Two slides were prepared for each experiment: one slide to be irradiated while the other serves as sham-irradiation control. The cells were irradiated with gamma photons from I-125 brachytherapy seeds in a plaque contained in a custom-built irradiation jig. The plaque was designed to achieve a relatively homogeneous dose distribution in the plane of the cell culture slide. Four sets of irradiation experiments were conducted at 370C at dose rates ranging from 2.1 cGy/hr to 4.5 cGy/hr. The dose rates were varied by varying the height of the cell culture slide above the plaque containing the I-125 seeds. Residual gammaH2AX was measured 24 hours after irradiation and used to compare the dose response of the cells with and without AuNP. In addition, the relative dose enhancement factor (DEF), representing the ratio of the dose to the cells with and without the presence of AuNP, was estimated from the data.
Results
From the dose response behavior, the results show that the biologic effect when irradiating with 0.2 mg/mL concentration of AuNP is up to 2.3 times greater than without AuNP. This major increase in radiation damage to cancer cells incubated with AuNP corresponds to an estimated DEF of over 3.5.
Conclusions
Our findings provide the first experimental evidence of substantial dose enhancement from gold nanoparticles during low dose rate gamma irradiation from brachytherapy sources. These in vitro study results provide impetus for further preclinical and clinical investigations in the development of gold nanoparticle-aided brachytherapy.
Cormack, R; Nguyen, P; D'Amico, AV; Sridhar, S; Makrigiorgos, GM
Locally Drug Enhanced Brachytherapy: A Comparison of 2 Approaches Based on Biologically Effective Dose Journal Article
In: International Journal of Radiation Oncology• Biology• Physics, vol. 84, no. 3, pp. S854–S855, 2012.
Abstract | BibTeX | Tags: Nanomedicine
@article{cormack2012locally,
title = {Locally Drug Enhanced Brachytherapy: A Comparison of 2 Approaches Based on Biologically Effective Dose},
author = {R Cormack and P Nguyen and AV D'Amico and S Sridhar and GM Makrigiorgos},
year = {2012},
date = {2012-01-01},
journal = {International Journal of Radiation Oncology• Biology• Physics},
volume = {84},
number = {3},
pages = {S854--S855},
publisher = {Elsevier},
abstract = {Purpose/Objective(s)
Permanent prostate brachytherapy may be enhanced by delivering radiosensitizer to the target during the implant process. Nanoparticles released from a substrate can deliver drug over an extended period of time and can be engineered to adjust their diffusion parameters. Nanoparticle eluting polymers have been proposed to coat radioactive sources or to form brachytherapy spacers as a way of delivering drug to the prostate. This work determines whether it is preferable to deliver radiosensitizer from sources or spacers.
Materials/Methods
The relative effectiveness of spacers or sources as sources of sensitizer was evaluated by comparing biologic effective dose (BED) of the combined effect of radiation and drug distributions within the prostate. Treatment plans of six patients receiving 125I prostate implants were analyzed under an IRB approved protocol. Target contours were extracted as were the locations of radioactive sources and spacers. Radiation dose was calculated according to AAPM TG43 methodology. Drug distributions were calculated from a solution of the diffusion equation, relative to the steady state concentration at the eluter's surface, for a range of diffusion-elimination modulus (φb) values and concentration needed for maximum sensitization (Cs). φb is viewed as a variable because the properties of the nanoparticles can be adjusted to affect diffusion and time of residence. Cs is treated as a variable because the amplitude of the drug distribution depends on the capacity of the implanted object and the time frame of release. BED calculations of the composite effect were done. The calculations were compared to an approach where the location of the spacers was allowed to be adjusted.
Results
The ratio of the BED for the two delivery approaches is presented in the 2D parameter space of φb and Cs. A full sensitization region, corresponding to low values of φb and Cs, shows no difference between approaches. The majority of the remaining parameter space, showed that using spacers to radiosensitize results in a greater BED. Changing the spacer locations from fixed by the treatment plan to adjustable allowed further increase of BED.
Conclusions
Using brachytherapy spacers as a vehicle to deliver radiosensitizing nanoparticles offers a greater potential to increase the effectiveness of prostate brachytherapy by in-situ radiosensitization. Further increase was achieved by treating spacer location as planning parameter. Using implanted non-radioactive devices for local radiosensitization suggests the potential of planned chemical distributions in conjunction with radiation planning to produce an optimal combined result.},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Permanent prostate brachytherapy may be enhanced by delivering radiosensitizer to the target during the implant process. Nanoparticles released from a substrate can deliver drug over an extended period of time and can be engineered to adjust their diffusion parameters. Nanoparticle eluting polymers have been proposed to coat radioactive sources or to form brachytherapy spacers as a way of delivering drug to the prostate. This work determines whether it is preferable to deliver radiosensitizer from sources or spacers.
Materials/Methods
The relative effectiveness of spacers or sources as sources of sensitizer was evaluated by comparing biologic effective dose (BED) of the combined effect of radiation and drug distributions within the prostate. Treatment plans of six patients receiving 125I prostate implants were analyzed under an IRB approved protocol. Target contours were extracted as were the locations of radioactive sources and spacers. Radiation dose was calculated according to AAPM TG43 methodology. Drug distributions were calculated from a solution of the diffusion equation, relative to the steady state concentration at the eluter's surface, for a range of diffusion-elimination modulus (φb) values and concentration needed for maximum sensitization (Cs). φb is viewed as a variable because the properties of the nanoparticles can be adjusted to affect diffusion and time of residence. Cs is treated as a variable because the amplitude of the drug distribution depends on the capacity of the implanted object and the time frame of release. BED calculations of the composite effect were done. The calculations were compared to an approach where the location of the spacers was allowed to be adjusted.
Results
The ratio of the BED for the two delivery approaches is presented in the 2D parameter space of φb and Cs. A full sensitization region, corresponding to low values of φb and Cs, shows no difference between approaches. The majority of the remaining parameter space, showed that using spacers to radiosensitize results in a greater BED. Changing the spacer locations from fixed by the treatment plan to adjustable allowed further increase of BED.
Conclusions
Using brachytherapy spacers as a vehicle to deliver radiosensitizing nanoparticles offers a greater potential to increase the effectiveness of prostate brachytherapy by in-situ radiosensitization. Further increase was achieved by treating spacer location as planning parameter. Using implanted non-radioactive devices for local radiosensitization suggests the potential of planned chemical distributions in conjunction with radiation planning to produce an optimal combined result.
2011
D.Plouffea, Brian; K.Nagesha, Dattatri; S.DiPietro, Robert; Sridhar, Srinvas; Heimand, Don; K.Murthya, Shashi; H.Lewisa, Lewis
Thermomagnetic determination of Fe3O4 magnetic nanoparticle diameters for biomedical applications Journal Article
In: Journal of Magnetism and Magnetic Materials, vol. 323, no. 17, pp. 2310-2317, 2011.
Abstract | Links | BibTeX | Tags: featured, Nanomedicine
@article{H.Lewisa2011,
title = {Thermomagnetic determination of Fe3O4 magnetic nanoparticle diameters for biomedical applications},
author = {Brian D.Plouffea and Dattatri K.Nagesha and Robert S.DiPietro and Srinvas Sridhar and Don Heimand and Shashi K.Murthya and Lewis H.Lewisa
},
doi = {S0304885311002423},
year = {2011},
date = {2011-09-01},
journal = {Journal of Magnetism and Magnetic Materials},
volume = {323},
number = {17},
pages = {2310-2317},
abstract = {The utility and promise of magnetic nanoparticles (MagNPs) for biomedicine rely heavily on accurate determination of the particle diameter attributes. While the average functional size and size distribution of the magnetic nanoparticles directly impact the implementation and optimization of nanobiotechnology applications in which they are employed, the determination of these attributes using electron microscopy techniques can be time-consuming and misrepresentative of the full nanoparticle population. In this work the average particle diameter and distribution of an ensemble of Fe3O4 ferrimagnetic nanoparticles are determined solely from temperature-dependent magnetization measurements; the results compare favorably to those obtained from extensive electron microscopy observations. The attributes of a population of biocompatible Fe3O4 nanoparticles synthesized by a thermal decomposition method are obtained from quantitative evaluation of a model that incorporates the distribution of superparamagnetic blocking temperatures represented through thermomagnetization data. The average size and size distributions are determined from magnetization data via temperature-dependent zero-field-cooled magnetization. The current work is unique from existing approaches based on magnetic measurement for the characterization of a nanoparticle ensemble as it provides both the average particle size as well as the particle size distribution.
},
keywords = {featured, Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Makrigiorgos, Robert A. Cormack; Paul L. Nguyen; Anthony V. D'Amico; Sri Sridhar; Mike
Optimal drug release schedule for in-situ radiosensitization of image guided permanent prostate implants Journal Article
In: Proceedings Volume 7964, Medical Imaging 2011: Visualization, Image-Guided Procedures, and Modeling, vol. 7964, no. 2011, 2011.
Abstract | Links | BibTeX | Tags: featured, Nanomedicine
@article{Makrigiorgos2011,
title = {Optimal drug release schedule for in-situ radiosensitization of image guided permanent prostate implants},
author = {Robert A. Cormack; Paul L. Nguyen; Anthony V. D'Amico; Sri Sridhar; Mike Makrigiorgos
},
doi = {10.1117/12.878139},
year = {2011},
date = {2011-03-03},
journal = {Proceedings Volume 7964, Medical Imaging 2011: Visualization, Image-Guided Procedures, and Modeling},
volume = {7964},
number = {2011},
abstract = {Planned in-situ radiosensitization may improve the therapeutic ratio of image guided 125I prostate brachytherapy. Spacers used in permanent implants may be manufactured from a radiosensitizer-releasing polymer to deliver protracted localized sensitization of the prostate. Such devices will have a limited drug-loading capacity, and the drug release schedule that optimizes outcome, under such a constraint, is not known. This work determines the optimal elution schedules for 125I prostate brachytherapy. The interaction between brachytherapy dose distributions and drug distribution around drug eluting spacers is modeled using a linear-quadratic (LQ) model of cell kill. Clinical brachytherapy plans were used to calculate the biologic effective dose (BED) for planned radiation dose distributions while adding the spatial distributions of radiosensitizer while varying the temporal release schedule subject to a constraint on the drug capacity of the eluting spacers. Results: The greatest increase in BED is achieved by schedules with the greatest sensitization early in the implant. Making brachytherapy spacers from radiosensitizer eluting polymer transforms inert parts of the implant process into a means of enhancing the effect of the brachytherapy radiation. Such an approach may increase the therapeutic ratio of prostate brachytherapy or offer a means of locally boosting the radiation effect without increasing the radiation dose to surrounding tissues.
},
keywords = {featured, Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Sridhar, Srinivas; Gultepe, Evin; Nagesha, Dattatri
Large scale nanoelement assembly method for making nanoscale circuit interconnects and diodes Miscellaneous
2011, (US Patent App. 12/936,938).
Abstract | BibTeX | Tags: Sensors
@misc{sridhar2011large,
title = {Large scale nanoelement assembly method for making nanoscale circuit interconnects and diodes},
author = {Srinivas Sridhar and Evin Gultepe and Dattatri Nagesha},
year = {2011},
date = {2011-02-01},
abstract = {Nanoelements such as single walled carbon nanotubes are assembled in three dimensions into a nanoscale template on a substrate by means of electrophoresis and dielectrophoresis at ambient temperature. The current-voltage relation indicates that strong substrate-nanotube interconnects carrying mA currents are established inside the template pores. The method is suitable for large-scale, rapid, three-dimensional assembly of 1,000,000 nanotubes per square centimeter area using mild conditions. Circuit interconnects made by the method can be used for nanoscale electronics applications.},
note = {US Patent App. 12/936,938},
keywords = {Sensors},
pubstate = {published},
tppubtype = {misc}
}
Sridhar, Srinivas; Campbell, Robert; Nagesha, Dattatri; Gultepe, Evin
Magnetic nanoplatforms for tumor targeting, imaging and energy delivery Miscellaneous
2011.
@misc{sridhar2011magnetic,
title = {Magnetic nanoplatforms for tumor targeting, imaging and energy delivery},
author = {Srinivas Sridhar and Robert Campbell and Dattatri Nagesha and Evin Gultepe},
year = {2011},
date = {2011-01-01},
publisher = {American Association for Cancer Research},
abstract = {We have developed magnetic nano-liposomes (MNL), incorporating superparamagnetic iron oxide nanoparticles (SPION), that are versatile theranostic nanoplatform for enhanced drug delivery and monitoring of cancer treatment. MNL are prepared with a formuation of DPPC:DOTAP:CHOL and DOPE-PEG5000. Incorporation of SPIONs results in MNL with mean diameter of 150-250 nm. MNL are easily taken up by B16-F10 melanoma, HUMVEC-D and breast cancer cell lines. They preferentially target the tumor vasculature as shown in a dorsal skin fold chamber using fluorescently labeled MNL. MNL display superparamagnetic response that is essential for magnetic targeting, MR contrast enhancement and magnetic heating.
MNL was administrated to SCID mouse with metastatic (B16-F10) melanoma grown in the right flank. Pre-injection and post-injection MR images were used to assess response to magnetic targeting effects. Biodistribution studies were conducted by 111In labeled MNL and amount of radioactivity recovered was used to confirm the effect of targeting for intratumoral administrations.
We have shown that tumor signal intensities in T2 weighted images decreased an average of 20±5% and T2* values decreased and average of 14±7ms in the absence of magnetic targeting. This compares to an average signal decrease of 57±12% and a decrease in T2* relaxation times of 27±8ms with the aid of external magnet showing up to 2-fold greater accumulation by magnetic targeting.
111In radio-labeled MNL have been shown to enable multi-modal imaging in vivo using MRI and SPeCT/CT. The images show that an MNL bolus injected intra-tumorally was retained in the tumor 24 hours after injection. Application of a magnetic field enables redistribution of the MNL in the tumor.
These MNL are also responsive to ac magnetic fields applied using a Copper coil at 360 kHz and 170A driving current. Both hyperthermia (upto 45C) and thermo-ablative temperatures upto 90C were achieved in 10 – 30 minutes ex vivo in buffer. The results indicate high efficiency for magnetic heating using MNL (Specific Absorption Rate ∼ 104 W/kg) and demonstrate the capability to couple ac magnetic fields to MNL to achieve any set of temperatures needed for hyperthermia and thermal ablation.
To date there are no truly theranostic platforms that have been approved for clinical use that combine targeting, thermal heating and MRI imaging capabilities. Existing FDA approved magnetic nanoparticle formulations like ferridex and ferumoxytol, are optimized for MR imaging, and have not been shown to be usable for thermal therapy.The MNL platform is a novel nanoplatform combining multi-modal imaging capabilities, with magnetic targeting and thermal therapy.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 380. doi:10.1158/1538-7445.AM2011-380
©2011 American Association for Cancer Research},
keywords = {MRI},
pubstate = {published},
tppubtype = {misc}
}
MNL was administrated to SCID mouse with metastatic (B16-F10) melanoma grown in the right flank. Pre-injection and post-injection MR images were used to assess response to magnetic targeting effects. Biodistribution studies were conducted by 111In labeled MNL and amount of radioactivity recovered was used to confirm the effect of targeting for intratumoral administrations.
We have shown that tumor signal intensities in T2 weighted images decreased an average of 20±5% and T2* values decreased and average of 14±7ms in the absence of magnetic targeting. This compares to an average signal decrease of 57±12% and a decrease in T2* relaxation times of 27±8ms with the aid of external magnet showing up to 2-fold greater accumulation by magnetic targeting.
111In radio-labeled MNL have been shown to enable multi-modal imaging in vivo using MRI and SPeCT/CT. The images show that an MNL bolus injected intra-tumorally was retained in the tumor 24 hours after injection. Application of a magnetic field enables redistribution of the MNL in the tumor.
These MNL are also responsive to ac magnetic fields applied using a Copper coil at 360 kHz and 170A driving current. Both hyperthermia (upto 45C) and thermo-ablative temperatures upto 90C were achieved in 10 – 30 minutes ex vivo in buffer. The results indicate high efficiency for magnetic heating using MNL (Specific Absorption Rate ∼ 104 W/kg) and demonstrate the capability to couple ac magnetic fields to MNL to achieve any set of temperatures needed for hyperthermia and thermal ablation.
To date there are no truly theranostic platforms that have been approved for clinical use that combine targeting, thermal heating and MRI imaging capabilities. Existing FDA approved magnetic nanoparticle formulations like ferridex and ferumoxytol, are optimized for MR imaging, and have not been shown to be usable for thermal therapy.The MNL platform is a novel nanoplatform combining multi-modal imaging capabilities, with magnetic targeting and thermal therapy.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 380. doi:10.1158/1538-7445.AM2011-380
©2011 American Association for Cancer Research
Lu, WT; Huang, YJ; Sridhar, S
Slow light using negative metamaterials Proceedings Article
In: Active Photonic Materials IV, pp. 80951D, International Society for Optics and Photonics 2011.
Abstract | BibTeX | Tags: Metamaterials and Nanophotonics
@inproceedings{lu2011slow,
title = {Slow light using negative metamaterials},
author = {WT Lu and YJ Huang and S Sridhar},
year = {2011},
date = {2011-01-01},
booktitle = {Active Photonic Materials IV},
volume = {8095},
pages = {80951D},
organization = {International Society for Optics and Photonics},
abstract = {A general overview of slow light waveguide structures made of negative metamaterials is presented. We discuss the conditions and the parameter space to achieve zero total energy flow and zero group velocity due to the degeneracy of forward and backward waves in waveguides cladded with single negative metamaterials. Absorptive loss plays a severely limiting role and can prevent achieving the zero group velocity condition. Gain can be introduced either in dielectric or negative metamaterials to restore the zero group velocity condition. This type of slow light waveguide has a large delay bandwidth product and is suitable for use in integrated optoelectronic circuits.
© (2011) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.},
keywords = {Metamaterials and Nanophotonics},
pubstate = {published},
tppubtype = {inproceedings}
}
© (2011) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Savo, Salvatore; Casse, BDF; Lu, Wentao; Sridhar, Srinivas
Observation of slow-light in a metamaterials waveguide at microwave frequencies Journal Article
In: Applied Physics Letters, vol. 98, no. 17, pp. 171907, 2011.
Abstract | BibTeX | Tags: Metamaterials and Nanophotonics
@article{savo2011observation,
title = {Observation of slow-light in a metamaterials waveguide at microwave frequencies},
author = {Salvatore Savo and BDF Casse and Wentao Lu and Srinivas Sridhar},
year = {2011},
date = {2011-01-01},
journal = {Applied Physics Letters},
volume = {98},
number = {17},
pages = {171907},
publisher = {American Institute of Physics},
abstract = {We report an experimental observation of slow-light in the GHz microwave regime utilizing the mechanism of the degeneracy of forward and backward waves in a planar waveguide consisting of a dielectric core cladded by single-negative metamaterial.
},
keywords = {Metamaterials and Nanophotonics},
pubstate = {published},
tppubtype = {article}
}
Ye, Yong-Hong; Huang, YJ; Lu, WT; Casse, BDF; Xiao, D; Bennett, SP; Heiman, D; Menon, L; Sridhar, S
Tuning the optical properties of metamaterials based on gold nanowire arrays embedded in alumina Journal Article
In: Optical Materials, vol. 33, no. 11, pp. 1667–1670, 2011.
Abstract | BibTeX | Tags: Metamaterials and Nanophotonics
@article{ye2011tuning,
title = {Tuning the optical properties of metamaterials based on gold nanowire arrays embedded in alumina},
author = {Yong-Hong Ye and YJ Huang and WT Lu and BDF Casse and D Xiao and SP Bennett and D Heiman and L Menon and S Sridhar},
year = {2011},
date = {2011-01-01},
journal = {Optical Materials},
volume = {33},
number = {11},
pages = {1667--1670},
publisher = {North-Holland},
abstract = {We fabricated a series of gold nanowires/alumina composite films with different wire lengths. Optical transmission measurements confirmed that the composite films exhibit transverse and longitudinal surface plasmon resonances. We show that the wavelength of the longitudinal resonance is sensitive to nanowire length, while that of the transverse resonance is not. The experimental results are in agreement with the modeled results based on the Maxwell Garnett effective medium theory. Moreover, the window for negative refraction of the samples can be tuned in synchronism with the longitudinal resonance by the nanowire length.},
keywords = {Metamaterials and Nanophotonics},
pubstate = {published},
tppubtype = {article}
}
Yavuzcetin, Ozgur; Ozturk, Birol; Xiao, Dong; Sridhar, Srinivas
Conicity and depth effects on the optical transmission of lithium niobate photonic crystals patterned by focused ion beam Journal Article
In: Optical Materials Express, vol. 1, no. 7, pp. 1262–1271, 2011.
Abstract | BibTeX | Tags: Sensors
@article{yavuzcetin2011conicity,
title = {Conicity and depth effects on the optical transmission of lithium niobate photonic crystals patterned by focused ion beam},
author = {Ozgur Yavuzcetin and Birol Ozturk and Dong Xiao and Srinivas Sridhar},
year = {2011},
date = {2011-01-01},
journal = {Optical Materials Express},
volume = {1},
number = {7},
pages = {1262--1271},
publisher = {Optical Society of America},
abstract = {We report on novel focused ion beam fabrication techniques that can greatly improve the optical performance of photonic crystal structures. The finite depth and conicity effects of holes and trenches in Lithium Niobate (LN) photonic crystals have been theoretically analyzed, showing that the conicity causes refraction into the bulk sample, resulting in high transmission loss and no useful spectral features. The techniques for reducing the conicity angle from 25° to 5° were explained for the focused ion beam (FIB) milled structures.
©2011 Optical Society of America},
keywords = {Sensors},
pubstate = {published},
tppubtype = {article}
}
©2011 Optical Society of America
Casse, BDF; Lu, WT; Huang, YJ; Sridhar, S
Robust method to determine the resolution of a superlens by analyzing the near-field image of a two-slit object Journal Article
In: arXiv preprint arXiv:1105.0182, 2011.
Abstract | BibTeX | Tags: Metamaterials and Nanophotonics
@article{casse2011robust,
title = {Robust method to determine the resolution of a superlens by analyzing the near-field image of a two-slit object},
author = {BDF Casse and WT Lu and YJ Huang and S Sridhar},
year = {2011},
date = {2011-01-01},
journal = {arXiv preprint arXiv:1105.0182},
abstract = {In the last decade, metamaterials-based superlenses, with a resolution below Abbe's diffraction limit, have emerged. To obtain a rough estimate of the resolution of such superlenses, imaging of two subwavelength slits, separated by a subwavelength gap textit{d} is typically performed. The resolution Δ of the lens corresponds to the minimum possible gap dmin for which a distinct image of the two slits can be resolved (Δ∼dmin). In this letter, we present a more quantitative estimate of the resolution of manufactured lenses by fitting analytical near-field image profiles, obtained from imaging a two-slit object with a theoretical negative-index lens of known resolution, to experimental data. We conclude the discussion by applying our analytical method to 3 case examples of superlensing from the literature. As shown, this method is particularly attractive for rapidly assessing the performance of fabricated superresolution lenses.},
keywords = {Metamaterials and Nanophotonics},
pubstate = {published},
tppubtype = {article}
}
Alvarado-Velez, Melissa; Rivera-Chacon, Delva M; Acevedo-Morantes, Claudia Y; Menon, Latika; Nagesha, Dattatri; Gultepe, Evin; Sridhar, Srinivas; Ramirez-Vick, Jaime E; Singh, Surinder P
Effects of fibronectin and vitronectin on human fetal osteoblast cell attachment and proliferation on nanostructured titania surfaces Proceedings Article
In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC 1155 16TH ST, NW, WASHINGTON, DC 20036 USA 2011.
BibTeX | Tags: Nanomedicine
@inproceedings{alvarado2011effects,
title = {Effects of fibronectin and vitronectin on human fetal osteoblast cell attachment and proliferation on nanostructured titania surfaces},
author = {Melissa Alvarado-Velez and Delva M Rivera-Chacon and Claudia Y Acevedo-Morantes and Latika Menon and Dattatri Nagesha and Evin Gultepe and Srinivas Sridhar and Jaime E Ramirez-Vick and Surinder P Singh},
year = {2011},
date = {2011-01-01},
booktitle = {ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY},
volume = {241},
organization = {AMER CHEMICAL SOC 1155 16TH ST, NW, WASHINGTON, DC 20036 USA},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {inproceedings}
}
Sridhar, Srinivas; Nagesha, Dattatri; Tada, Dayane; Kumar, Rajiv; Makrigiorgos, Mike G; Cormack, Robert
Radio-sensitizer eluting nanoporous coatings on fiducials markers: Biological in-situ dose-painting for IGRT Miscellaneous
2011.
Abstract | BibTeX | Tags: Nanomedicine
@misc{sridhar2011radio,
title = {Radio-sensitizer eluting nanoporous coatings on fiducials markers: Biological in-situ dose-painting for IGRT},
author = {Srinivas Sridhar and Dattatri Nagesha and Dayane Tada and Rajiv Kumar and Mike G Makrigiorgos and Robert Cormack},
year = {2011},
date = {2011-01-01},
publisher = {American Association for Cancer Research},
abstract = {Image-guided radiation treatments routinely utilize implantable devices, such as radio-opaque fiducials or brachytherapy spacers, for improved spatial accuracy. We study the hypothesis that the therapeutic efficiency of IGRT can be further enhanced by biological in-situ dose painting (BIS-IGRT) using local delivery of radiosensitizers embedded within nanoparticles and nanoporous polymer matrices coating gold fiducial markers. Biocompatible polymers loaded with model molecules were coated as a thin film on gold fiducials. The nanoporous morphology of the polymer coatings allowed the controlled release of the molecules and nanoparticles. Two experimental approaches were studied: (i) a free drug release system Doxorubicin, a hydrophilic drug in Poly(methyl methacrylate (PMMA) coating and (ii) Poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles loaded with Coumarin-6, a model for a fluorescent hydrophobic drug, in a chitosan matrix applied as fiducial coating. Temporal release kinetics measurements in buffer were carried out using fluorescence spectroscopy. For flat gold films and gold fiducials coated with Doxorubicin in PMMA matrix, an initial release of Dox within the first few hours was followed by a sustained release over the course of next 3 months. Release of Dox from within PMMA matrix is dependent on the concentration of Dox, ratio of PMMA/Dox, thickness of PMMA/Dox coating on gold surface. The release profile of coumarin-6 loaded nanoparticles from chitosan film on gold fiducials showed a continuous release of NPs from the coating during forty days. (63±10)% of NPs were released in twenty days. After that, the release became slower and additional 37% of release was observed after twenty-days. Spatial release profiles in an agarose phantom were also measured and compared with release kinetics models. Results show that dosage and rate of release of these radiosensitizers can be precisely tailored to achieve the desired release profile for BIS-IGRT.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2674. doi:10.1158/1538-7445.AM2011-2674
©2011 American Association for Cancer Research},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {misc}
}
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2674. doi:10.1158/1538-7445.AM2011-2674
©2011 American Association for Cancer Research
Savo, Salvatore; Lu, Wentao T; Casse, Bernard Didier F; Sridhar, Srinivas
SLOW LIGHT IN NEGATIVE PERMEABILITY METAMATERIAL WAVEGUIDES Book Section
In: Selected Topics In Photonic Crystals And Metamaterials, pp. 373–387, 2011.
Abstract | BibTeX | Tags: Metamaterials and Nanophotonics
@incollection{savo2011slow,
title = {SLOW LIGHT IN NEGATIVE PERMEABILITY METAMATERIAL WAVEGUIDES},
author = {Salvatore Savo and Wentao T Lu and Bernard Didier F Casse and Srinivas Sridhar},
year = {2011},
date = {2011-01-01},
booktitle = {Selected Topics In Photonic Crystals And Metamaterials},
pages = {373--387},
abstract = {The ability to slow and even stop-light is crucial for the realization of all-optical integrated circuitry. In this chapter we present a design approach for realizing slow-light devices in the microwave band of frequency. Slow light can be achieved in a simple planar waveguide cladded with single negative metamaterial. Our device consists of a planar waveguide having a dielectric core and a negative permeability metamaterial. The negative permeability is obtained by arranging periodically split ring resonators (SRRs). We introduce a theoretical model, valid for both TE and TM modes, which describes light propagation in planar waveguides with single negative cladding, then we propose a prototype structure for TE mode working at 9.87GHz. The current design strategy relies on numerical simulations of the electromagnetic properties of SRRs which provide the scattering parameters. A parameters retrieval method has been used to extract the design window for the permeability and the permittivity.},
keywords = {Metamaterials and Nanophotonics},
pubstate = {published},
tppubtype = {incollection}
}
2010
Casse, Bernard Didier F; Sridhar, Srinivas
Superresolution imaging and superfocusing with negative-index metamaterials Journal Article
In: 2010.
Abstract | BibTeX | Tags: Metamaterials and Nanophotonics
@article{cassesuperresolution,
title = {Superresolution imaging and superfocusing with negative-index metamaterials},
author = {Bernard Didier F Casse and Srinivas Sridhar},
year = {2010},
date = {2010-03-19},
abstract = {Developments in higher-resolution optics have often led to rapid scientific and technological progress in the life sciences and engineering. In 1873, Ernst Abbe showed1 that the spatial resolution of optical-imaging instruments is limited by diffraction because of the finite wavelength of light. Abbe’s diffraction-limit theory implies that the resolving power of optical components cannot be smaller than half the wavelength of the incident light. Nanoscale optical elements that can mold the flow of light offer the potential of entirely new modalities of superresolution imaging. With a vision to build superlenses capable of resolving subwavelength details, in the last decade the photonics community has focused on fabricating tiny metallic inclusions (or, closely related, plasmonic architectures) characterized by a negative index of refraction. 2 Unfortunately, such metamaterials suffer from material losses enhanced by resonances, leading to a degradation of functionality. Instead, our group has demonstrated successful performance of highly functional nanostructured metamaterials in ‘low-loss’ dielectric platforms such as metal-dielectric composites and III-V semiconductors (composed of indium phosphide/indium gallium arsenide phosphide: InP/InGaAsP). We recently reported the experimental realization of superresolution imaging with a low-loss 3D nanolens, 3 comprised of gold nanowires embedded in nanoporous alumina: see Figure 1 (right). This 3D nanolens, manufactured using a combination of bottom-up self-assembly and electrochemical process, transmits subwavelength details down to= 4 (: Wavelength) and over a significant distance of more than …},
keywords = {Metamaterials and Nanophotonics},
pubstate = {published},
tppubtype = {article}
}
Gultepe, Evin; Nagesha, Dattatri; Sridhar, Srinivas; Amiji, Mansoor
Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices Journal Article
In: Advanced drug delivery reviews, vol. 62, no. 3, pp. 305–315, 2010.
Abstract | BibTeX | Tags: Nanomedicine
@article{gultepe2010nanoporous,
title = {Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices},
author = {Evin Gultepe and Dattatri Nagesha and Srinivas Sridhar and Mansoor Amiji},
year = {2010},
date = {2010-01-01},
journal = {Advanced drug delivery reviews},
volume = {62},
number = {3},
pages = {305--315},
publisher = {Elsevier},
abstract = {The characteristics of nanoporous inorganic coatings on implants or on implantable devices are reviewed. The commonly used nanoporous materials, such as aluminum oxide (Al2O3), titanium oxide (TiO2) and porous silicon are highlighted with illustrative examples. The critical issues for sustained release systems are examined and the elution pro?les of nanoporous coatings are discussed. The available data shows that these systems can be used effectively for sustained release applications. They satisfy the basic biocompatibility tests, meet the requirements of drug loading and sustained release pro?les extending to several weeks and also are compatible with current implant technologies. Nanoporous inorganic coatings are well suited to provide improved ef?cacy and integration of implants in a variety of therapeutic situations.
},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Casse, BDF; Lu, WT; Huang, YJ; Gultepe, E; Menon, L; Sridhar, S
Super-resolution imaging using a three-dimensional metamaterials nanolens Journal Article
In: Applied Physics Letters, vol. 96, no. 2, pp. 023114, 2010.
Abstract | BibTeX | Tags: Metamaterials and Nanophotonics
@article{casse2010super,
title = {Super-resolution imaging using a three-dimensional metamaterials nanolens},
author = {BDF Casse and WT Lu and YJ Huang and E Gultepe and L Menon and S Sridhar},
year = {2010},
date = {2010-01-01},
journal = {Applied Physics Letters},
volume = {96},
number = {2},
pages = {023114},
publisher = {American Institute of Physics},
abstract = {Super-resolution imaging beyond Abbe’s diffraction limit can be achieved by utilizing an optical medium or “metamaterial” that can either amplify or transport the decaying near-field evanescent waves that carry subwavelength features of objects. Earlier approaches at optical frequencies mostly utilized the amplification of evanescent waves in thin metallic films or metal-dielectric multilayers, but were restricted to very small thicknesses (⪡λ, wavelength) and accordingly short object-image distances, due to losses in the material. Here, we present an experimental demonstration of super-resolution imaging by a low-loss three-dimensional metamaterial nanolens consisting of aligned gold nanowires embedded in a porous alumina matrix. This composite medium possesses strongly anisotropic optical properties with negative permittivity in the nanowire axis direction, which enables the transport of both far-field and near-field components with low-loss over significant distances (>6λ), and over a broad spectral range. We demonstrate the imaging of large objects, having subwavelength features, with a resolution of at least λ/4 at near-infrared wavelengths. The results are in good agreement with a theoretical model of wave propagation in anisotropic media.
The authors would like to thank M. G. Silveirinha, D. Heiman, J. Sokoloff, and F. Camino for useful discussions and comments. This work was financially supported by the Air Force Research Laboratories, Hanscom through Grant No. FA8718-06-C-0045 and NSF through Grant No. PHY-0457002. The work was also performed in part at the Kostas Center at Northeastern University and the Center for Nanoscale Systems, a member of NNIN, which is supported by the National Science Foundation under NSF Award No. ECS-0335765. Research carried out in part at the Center for Functional Nanomaterials, Brookhaven National Laboratory, which is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-98CH10886.},
keywords = {Metamaterials and Nanophotonics},
pubstate = {published},
tppubtype = {article}
}
The authors would like to thank M. G. Silveirinha, D. Heiman, J. Sokoloff, and F. Camino for useful discussions and comments. This work was financially supported by the Air Force Research Laboratories, Hanscom through Grant No. FA8718-06-C-0045 and NSF through Grant No. PHY-0457002. The work was also performed in part at the Kostas Center at Northeastern University and the Center for Nanoscale Systems, a member of NNIN, which is supported by the National Science Foundation under NSF Award No. ECS-0335765. Research carried out in part at the Center for Functional Nanomaterials, Brookhaven National Laboratory, which is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-98CH10886.
Stambaugh, C; Tada, D; Nagesha, D; Jost, E; Levy, C; Cormack, RA; Makrigiorgos, M; Sridhar, S
WE-E-204B-02: Release Kinetics of Radio-Sensitizers from Nanoporous Coatings on Gold Fiducials: Biological In-Situ Dose-Painting for IGRT Journal Article
In: Medical Physics, vol. 37, no. 6Part13, pp. 3437–3438, 2010.
BibTeX | Tags: Nanomedicine
@article{stambaugh2010we,
title = {WE-E-204B-02: Release Kinetics of Radio-Sensitizers from Nanoporous Coatings on Gold Fiducials: Biological In-Situ Dose-Painting for IGRT},
author = {C Stambaugh and D Tada and D Nagesha and E Jost and C Levy and RA Cormack and M Makrigiorgos and S Sridhar},
year = {2010},
date = {2010-01-01},
journal = {Medical Physics},
volume = {37},
number = {6Part13},
pages = {3437--3438},
publisher = {American Association of Physicists in Medicine},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Cormack, Robert A; Nagesha, Dattatri; Gultepe, Evin; Nguyen, Paul; D'Amico, Anthony V; Sridhar, Srinivas; Makrigiorgos, Mike
Drug Eluting Brachytherapy Spacers: A Potential for Biologically-Enhanced Brachytherapy Journal Article
In: Brachytherapy, vol. 9, pp. S48–S49, 2010.
Abstract | BibTeX | Tags: Nanomedicine
@article{cormack2010drug,
title = {Drug Eluting Brachytherapy Spacers: A Potential for Biologically-Enhanced Brachytherapy},
author = {Robert A Cormack and Dattatri Nagesha and Evin Gultepe and Paul Nguyen and Anthony V D'Amico and Srinivas Sridhar and Mike Makrigiorgos},
year = {2010},
date = {2010-01-01},
journal = {Brachytherapy},
volume = {9},
pages = {S48--S49},
publisher = {Elsevier},
abstract = {Purpose: Ultrasound-guided prostate brachytherapy routinely implants spacers between the 125I radiation sources, that provide no therapeutic benefit although they are essential to the technical completion of the implant. The spacers offer a vehicle for in-situ delivery of radio-sensitizer, or other agents, which could increase the biologic effective dose of the radiation. This work studies the achievable drug coverage as a function of the chemical and physical properties of the drugs and devices.
Materials and Methods: Fluorescent doxorubicin in a polymer suspension and gold substrate were used to evaluate the ability to create a radio-opaque drug eluter. Elution kinetics from polymer coating of gold substrate was measured via fluorescence spectrometry. An analytic solution to the diffusion elimination equation was used to perform computer modeling of drug distributions produced by configurations of eluters placed within ultrasound guided prostate implants. Measures of tumor coverage and normal tissue involvement are evaluated for multiple combinations of eluter sizes and diffusion elimination moduli φb.
Results: Timed-release of doxorubicin from a polymer coating on a gold substrate, as shown in the top half of the figure, is technically possible. The many spacers used in prostate brachytherapy are sufficient to sensitize a portion of the prostate with values of φb close to the calculated ones. The use of drug-eluting brachytherapy spacers would enable a more localized enhancement in biologic effective dose than what can be delivered by a local brachytherapy boost. The bottom half of the figure shows a prostate implant at treated at our institution and and how it could be locally enhanced with the addition of a small number of drug eluting spacers.
Conclusions: IGRT techniques, such as ultrasound-guided brachytherapy, already implant devices within tumors as part of the standard of care. These devices may be enhanced with drug-eluting coatings to provide an in-situ increase in biologic effective dose without increasing the physical dose involved in the therapy. Generalization of this biologically in-situ enhanced IGRT (BIS-IGRT) to other agents in combination with advances in biologic imaging may provide an opportunity for personalized biologically in-situ enhanced brachytherapy.},
keywords = {Nanomedicine},
pubstate = {published},
tppubtype = {article}
}
Materials and Methods: Fluorescent doxorubicin in a polymer suspension and gold substrate were used to evaluate the ability to create a radio-opaque drug eluter. Elution kinetics from polymer coating of gold substrate was measured via fluorescence spectrometry. An analytic solution to the diffusion elimination equation was used to perform computer modeling of drug distributions produced by configurations of eluters placed within ultrasound guided prostate implants. Measures of tumor coverage and normal tissue involvement are evaluated for multiple combinations of eluter sizes and diffusion elimination moduli φb.
Results: Timed-release of doxorubicin from a polymer coating on a gold substrate, as shown in the top half of the figure, is technically possible. The many spacers used in prostate brachytherapy are sufficient to sensitize a portion of the prostate with values of φb close to the calculated ones. The use of drug-eluting brachytherapy spacers would enable a more localized enhancement in biologic effective dose than what can be delivered by a local brachytherapy boost. The bottom half of the figure shows a prostate implant at treated at our institution and and how it could be locally enhanced with the addition of a small number of drug eluting spacers.
Conclusions: IGRT techniques, such as ultrasound-guided brachytherapy, already implant devices within tumors as part of the standard of care. These devices may be enhanced with drug-eluting coatings to provide an in-situ increase in biologic effective dose without increasing the physical dose involved in the therapy. Generalization of this biologically in-situ enhanced IGRT (BIS-IGRT) to other agents in combination with advances in biologic imaging may provide an opportunity for personalized biologically in-situ enhanced brachytherapy.
Lu, WT; Huang, YJ; Casse, BDF; Banyal, RK; Sridhar, S
Storing light in active optical waveguides with single-negative materials Journal Article
In: Applied Physics Letters, vol. 96, no. 21, pp. 211112, 2010.
Abstract | BibTeX | Tags: Metamaterials and Nanophotonics
@article{lu2010storing,
title = {Storing light in active optical waveguides with single-negative materials},
author = {WT Lu and YJ Huang and BDF Casse and RK Banyal and S Sridhar},
year = {2010},
date = {2010-01-01},
journal = {Applied Physics Letters},
volume = {96},
number = {21},
pages = {211112},
publisher = {American Institute of Physics},
abstract = {We show that a nonresonant planar waveguide consisting of conventional dielectric cladded with single-negative materials supports degenerate propagating modes for which the group velocity and total energy flow can be zero if the media are lossless. Absorptive losses will destroy the zero-group velocity condition for real frequency/complex wave vector modes.
},
keywords = {Metamaterials and Nanophotonics},
pubstate = {published},
tppubtype = {article}
}


